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Foreword
Measuring and Improving Cost, Cost-Effectiveness, and Cost-Benefit
for Substance Abuse Treatment Programs: A Manual takes the mystery
out of cost accounting. Treatment programs, regardless of their fund-
ing sources, are faced with constant pressures to keep costs to a mini-
mum and to justify every expenditure. Yet accounting for costs takes
time that might better be spent on treatment itself. Also, program staff
trained in helping people may not be proficient in tracking money.
The National Institute on Drug Abuse, as part of its mission to assist
programs that treat substance abusers, has sponsored research related
to cost issues. The results of these studies are available to treatment
programs at no cost as part of NIDA’s policy of transferring technology
as soon as possible. One example of this is Measuring and Improving
Cost, Cost-Effectiveness, and Cost-Benefit for Substance Abuse Treat-
ment Programs: A Manual.
The manual describes several ways to determine cost effectiveness and
benefits, ranging from simple educated estimates to sophisticated,
computerized methods. It even shows you how to find people at little
or no cost to help you collect and analyze the data.
No background in accounting or research is needed to use the methods
described in the manual. The hands-on format and step-by-step in-
structions, exercises, and worksheets are designed to guide profession-
als from a variety of disciplines and educational backgrounds through
the collection and analysis of data on costs, procedures, effectiveness,
and benefits. Most of these data are already being collected for other
purposes, such as billing or evaluating patient progress.
What Does the Manual Contain
The methodology used in this manual is based on a cost-procedure-
process-outcome analysis (CPPOA) model that has been well re-
searched and tested with substance abuse treatment programs.
The manual itself consists of 12 chapters, starting with definitions of
various cost analyses and explaining their importance. A suggested
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timetable breaks the measurement process into specific tasks, identi-
fies who needs to be involved, and presents concrete assignments for
each person on the data collection and analysis team.
Then the manual explains the model on which it is based and helps
you define your own program in terms of your resources, procedures,
processes, and outcomes. This exercise alone can reveal many things
about your program, both its strengths and its weaknesses.
Detailed, step-by-step instructions and suggestions are given for—
 Collecting and analyzing cost data.
 Collecting patient data.
 Finding the cost-effectiveness of your procedures and processes.
 Exploring cost benefits.
 Using your findings to improve your program.
Collecting and
Analyzing Cost
Data
The manual defines various categories of costs and spells out strate-
gies for collecting data. Most costs are already known to someone in
the program; your task is to get all the information in one place. Pro-
vider time may need to be taken from individual patient records. Per-
sonnel will know salaries and wages. Your administrator will probably
have records on the cost of space and utilities. Whoever pays the bills
will know the cost of medications, transportation, and so forth.
The manual provides sample forms and formats for putting these data
together for easy analysis. When your data collection plan is in place,
the actual time required to implement it will be minimal.
Analyzing the data is simply finding the cost of each procedure for each
patient for the month or quarter. With all the numbers in one place, this
can be done by hand or using a calculator, although a computer spread-
sheet program might be more efficient.
Collecting Patient
Data
The manual describes the types of data you will want to collect for each
patient. Again, most of this is already available from intake forms and
progress reports. Several ways of coding patient progress are sug-
gested.
Finding the Cost-
Effectiveness of
Your Procedures
and Processes
The measures of patient progress show the effectiveness of your proce-
dures. The manual provides several ways to turn measures of effective-
ness into measures of monetary benefits.
Methods for analyzing data with graphs and spreadsheets are
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explained using examples from substance abuse programs. Sample ta-
bles, charts, and report outlines describe ways to present the findings
to others.
Exploring Cost
Benefits
The manual also discusses ways to show the cost benefits of your pro-
gram. These include the many savings for the community related to the
costs of crime, unemployment, and health services for untreated sub-
stance abusers. It also shows how treatment increases community
income.
Using Your
Findings To
Improve Your
Program
Determining the cost and effectiveness of your procedures gives you
the necessary information for improving your program. The manual
explains several ways to compare your program to other programs and
to compare procedures within your program. It also points out the pit-
falls of certain comparisons.
The manual suggests a variety of changes you might try that could save
money without jeopardizing your program. It even suggests ways to
save time and money on measuring costs.
Is This Method Realistic for a Clinical Program?
The last chapter of the manual gives a detailed illustration of how the
CPPOA model was used by the staff and administrators of an actual sub-
stance abuse treatment program. It takes you step by step through their
experience, showing how they made decisions, how their view of their
program changed during the process, what they learned, and how they
applied their findings to improving their program.
You will find that the greatest expenditure of time is in the early plan-
ning stages when you are defining your program and what you want to
know about it — or what your funders want. Once these decisions are
made, data collection requires very little time. It can be part of the daily
routine for everyone or a periodic job for one person.
Once a month or quarter, analyzing the data and preparing usable re-
ports may take one person several hours or a couple of days, depend-
ing on your method. You will probably spend just as much time review-
ing your program and looking for ways to improve it as before, but
armed with your cost-effectiveness reports, you can make better in-
formed decisions and be assured of more predictable results.
The ability to show concrete evidence of your contribution to the com-
munity through cost-benefit analysis will also help you raise additional
funds. Can you afford not to thoroughly examine the relationship of
your costs to your program’s results?
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Introduction
Why Analyze Costs and Benefits?
Intense competition for limited substance abuse program funds, com-
bined with increased scrutiny of program costs and outcomes, has cre-
ated a need for better understanding of how costs and outcomes are re-
lated in substance abuse treatment. Programs are increasingly called
on to show that their treatment of substance-abusing patients is a good
investment of public and private funds. Program costs must be justified
relative to program outcomes (and vice versa).
There are several advantages to analyzing costs, cost-effectiveness, and
cost-benefits. Concise but accurate reports of how much a service costs
can help raise funds. Potential contributors may be impressed that you
know both where the money is going and how much it takes to run dif-
ferent parts of the program. Having solid reports of the effectiveness
and cost-effectiveness of your program will assure donors that their
contributions will have the maximum impact possible.
Critics will find it harder to dismiss funding requests as being too high
when a careful and complete accounting of all resources used by the
program shows their true value and the true cost of providing the ser-
vices. Critics also will find it more difficult to dismiss your funding re-
quests as wasted money when you can show what is achieved as well as
what is done with the funds.
Some funding agencies require regular cost analyses to justify reim-
bursement for services provided. They may require that you verify your
implementation of treatment procedures to account for your ex-
penses. Many agencies set a ceiling on costs. A few agencies may even
require that you demonstrate at least minimum levels of effectiveness
for no more than a maximum allowable cost. These agencies and critics
may be more impressed if you can show that your program not only un-
derstands the relationship between funds spent and effectiveness
achieved, but also attempts to measure the social and other monetary
benefits of treatment.
Acknowledging that substance abuse treatment benefits society by re-
ducing the burden of substance-abusing patients on health care and
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other social service and criminal justice systems helps to ensure contin-
ued funding for your program. One of the most powerful ways to ac-
knowledge this purpose is to measure your program’s savings in health
care and other services. If your program saves substantially more
money than it consumes, it will be easier to defend as a form of social
investment that may deserve more attention and additional funds.
Do not worry that analyzing the cost-effectiveness and cost-benefit of
your substance abuse program will produce negative findings. Pro-
grams and researchers have conducted cost-related analyses since the
1970s. Some of their findings are included in this manual, along with
some of the methods they used to attain them. Program evaluators gen-
erally have answered the question, Is treatment of substance abuse
cost-effective or cost-beneficial? with a qualified or resounding yes.
A review of research by Jones and Vischi (1979), for example, con-
cluded that “the studies are nearly unanimous in finding that subse-
quent to treatment for ADM [alcoholism, drug abuse, and mental ill-
ness] disorders there is a reduction in the utilization of general health
care services” (p. iii). Also, Hubbard and French (1991) reviewed re-
search showing that “there was a four-to-one return on the investment
of tax dollars for law-abiding citizens for methadone and residential
programs” and “the crime-reduction impact estimated here represents
only a portion of the potential savings attributable to drug abuse treat-
ment” (p. 98). A study conducted by the State of Oregon concluded,
“Thus, every tax dollar spent on treatment produced $5.60 in avoided
costs to the taxpayer” (Finigan 1996, p. ii).
Definitions of Terms
We begin by defining important terms. Program funders, patients, and
evaluators often confuse the terms cost analysis, cost-effectiveness
analysis, and cost-benefit analysis. This section explains what each
type of analysis involves and why it is important.
Cost Analysis A thorough description of the type and amount of all resources used to
produce substance abuse treatment services. Cost analyses are criti-
cally important for deciding how to allocate funds within a program
and for understanding the relationships between costs and outcomes.
Examining cost figures for the program as a whole (or for parts of it) is a
basic form of cost analysis. Most accounting services provide cost analy-
ses in the form of a monthly or quarterly report. Costs typically are pro-
vided at several levels, from the total cost of the program for the entire
period to the cost of each part of the program each day. Costs generally
vary over time.
Introduction
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Costs also can be tallied for each patient and for each month for each
patient. This is often done for billing or reimbursement. For example, a
program’s cost records might show that $355 was spent to treat the av-
erage patient during a month. Cost per patient per month can vary over
time and depends on a host of factors from type of treatment to pro-
gram size.
Cost-Effectiveness
Analysis
The relationship between program costs and program effectiveness,
that is, patient outcome. Costs are measured as dollars spent, whereas
effectiveness or outcome is measured as changes in patients’ behav-
iors, thoughts, feelings, or biology. For example, the cost-effectiveness
of an opiate treatment program might be measured as the cost of gener-
ating an opiate-free month for the average patient.
There is no single standard for “cost-effective.” Generally, the term is
used loosely as a way of saying that something probably costs less, or is
more effective, than something else. Cost-effectiveness indices can be
compared for different programs, different treatment modalities (such
as residential versus outpatient clinics), and different treatment tech-
niques (such as drug-free with or without acupuncture or drug-free
versus methadone maintenance).
The overall cost-effectiveness of a program can be improved by first
finding which parts of the program contribute most to effectiveness
and then discovering which of those program components have the
lowest cost. Although substance abuse treatment programs are com-
plex, it may be possible to improve cost-effectiveness by enhancing use
of these more effective and less expensive components while decreas-
ing use of less effective and more expensive components.
However, cost-effectiveness indicators vary somewhat over time and
over patients because of many factors, not all of which are controlled by
the program. It is easy to find an apparent difference in the cost-
effectiveness of different program components or different programs.
It is harder to show that the difference is real—for example, that it oc-
curs reliably over months and for most patients and therefore should
be used in program management decisions.
Cost-Benefit
Analysis
The measurement of both costs and outcomes in monetary terms.
Costs and benefits can be compared between programs or contrasted
within a single program. Cost-benefit analysis can also discover
whether program expenditures are less than, similar to, or greater than
program benefits. The time it takes for program benefits to exceed pro-
gram costs is also measured in some cost-benefit analyses. Cost-benefit
findings can often stand alone. For example, consider the inherent
value of finding that every $1 spent for a particular substance abuse
treatment program results in average savings of $4.96 to the taxpayer.
Definitions of Terms
3
Some drug treatment programs produce measurable monetary out-
comes, like increased days of legitimate employment and decreased
job absences. Increased employment can yield increased income,
which yields increased tax revenues. In addition, drug treatment pro-
grams may reduce patients’ use of food stamps, public health services,
and other public assistance—a potentially huge cost savings.
These cost savings may not occur as soon as patients begin treatment.
Social service costs may actually rise as patients are guided to social ser-
vices they need for recovery. In a few months or years, however, social
service costs may decrease, whereas patient income and taxes paid by
patients may increase.
Other major benefits of substance abuse treatment programs are indi-
rect or secondary, such as reduction in crime-related costs, including
property losses, medical services required by victims, time taken off
from work by victims, and costs of apprehending, trying, and incarcer-
ating offenders. All of these income increments, tax payments, and cost
savings can add up to a considerable total benefit that exceeds the cost
of treatment several times over.
There are several ways to report the relationships between costs and
benefits:
 The net benefit of a program can be shown by subtracting the
costs of a program from its benefits. For example, if a substance
abuse treatment program cost $100,000 per year but generated
in the same year $500,000 in increased patient income, in-
creased tax payments by patients, and reduced expenditures for
social and criminal justice services, the net benefit of the pro-
gram would be $500,000 minus $100,000, or $400,000, for that
year.
 The ratio of benefits to costs is found by dividing total program
benefits by total program costs. For example, dividing the
$500,000 benefit of the program by its $100,000 costs yields a
cost-benefit ratio of 5:1.
 Because neither net benefits nor cost-benefit ratios indicate the
size of the cost (initial investment) required for treatment to
yield the observed benefits, it is important to report this as well.
We cannot assume that the same exact relationships between
costs and benefits will exist at different levels of investment.
Sometimes an increase in cost allows new, more productive pro-
cedures to be used for treatment, increasing benefits dramati-
cally. For example, increasing a program budget to allow hiring
of a community liaison, vocational counselor, or physician might
dramatically increase patient outcome. Therefore, it often is best
to report the initial investment, the net benefit, and the cost-
benefit ratio.
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 The time to return on investment (the time it takes for program
benefits to equal program costs) is yet another indicator used in
cost-benefit analysis. For programs, benefits and costs occur at
the same time, or at least in the same year. For individual pa-
tients, however, the investment in treatment may pay off sub-
stantially only after several months or years. Costs usually occur
up front, but program benefits may take time to reach the point
where they exceed costs.
 The decreasing value of benefits attained in the distant future
can be calculated as the present value of benefits. When most of
the cost of treatment occurs in the first year of treatment but
most benefits occur only several years after treatment, the value
of those delayed benefits needs to be adjusted (decreased) to re-
flect the delay.
Analyses of cost, cost-effectiveness, and cost-benefit relationships can
provide valuable insights into how a program operates and how its op-
erations could be improved to serve more people better for less. Analy-
ses of costs, cost-effectiveness, and cost-benefit also show funders that
program managers are aware of the importance of accountability—ac-
countability for how funds are used and what they are used to achieve.
Additional Resources
Collecting information on costs, procedures, effectiveness, and bene-
fits and analyzing these data is a lot of work. Help may be available to
you from several sources.
Literature Recommendations for how to measure the cost and cost-effectiveness
of substance abuse treatment are available from several sources other
than this manual (e.g., Apsler and Harding 1991). Cartwright and Kaple
(1991) provide a sophisticated discussion of issues and initial findings
of large-scale cost and cost-effectiveness analyses of substance abuse
treatments.
Cost assessment methods for a variety of substance abuse treatment
settings are detailed by Anderson and colleagues (in press), Bradley
and associates (1994), and French and colleagues (1994). Nas (1996)
provides a sophisticated, detailed description of multiple methods of
cost-benefit analysis for a variety of human services. French and associ-
ates (1996) propose detailed steps for converting the outcomes of sub-
stance abuse treatment programs into monetary units. Yates (1980,
1995, 1996) describes the model used in this manual to conduct im-
provement-oriented analyses of cost-effectiveness and cost-benefit.
Additional Resources
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Other Programs Other programs similar to yours probably have measured their effec-
tiveness and perhaps their costs and benefits. Directors of those pro-
grams may be willing to describe their experiences and advise you
about which measures and types of analyses worked for them.
Universities Almost every university and 4-year college has faculty who are knowl-
edgeable about measurement issues in real-world settings such as
yours. You are most likely to find these faculty in schools or depart-
ments of accounting, business, economics, education, political sci-
ence, psychology, public health, social work, and sociology. Graduate
and undergraduate students in these departments often must collect
and analyze data for their theses. Professors also must analyze data and
publish findings to advance in their careers. If you can supply access to
your program, some professors and students may be able to provide
you with data and analyses of costs, effectiveness, and benefits.
High schools also may have teachers and advanced students who can
assist. Using these resources not only can save you time and money, but
also can build or reinforce ties between your program and the
community.
Businesses Computer spreadsheet software might be donated by local businesses
and agencies that are upgrading their software. Older computers that
still work well and run good spreadsheet software also may be available
as donations from local businesses and agencies.
Governments This manual is an example of the help that you can get from local, State,
and Federal Government agencies at little or no cost. These govern-
ment resources may have programs that provide technical assistance in
program evaluation or program management. Additional funds some-
times are available to conduct the analyses described here. Local and
State agencies may be eager to help once they realize that continued
funding of your program by Federal agencies or other funders may be a
smoother process if you have begun conducting cost, cost-effective-
ness, and cost-benefit analyses.
Introduction
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Getting Started
Planning is essential for analyses of costs, cost-effectiveness, and
cost-benefit. Building from one basic measure to a few, and from one
simple analysis to several, makes the process less disruptive to treat-
ment as well as more complete and, therefore, more accurate.
Timetable
A suggested timetable for developing cost-related analyses for your
program is presented in table 1. Each step begins where the arrow line
starts and ends at the tip of the arrowhead. Small, brief initial steps
eventually give way to longer subsequent steps.
Data Collection Measures for cost, treatment procedures, effectiveness, and benefits
are developed and tested over several weeks. The timetable includes
measures to detect whether and to what extent the specific procedures
of treatment were put into effect. Two weeks are allotted for develop-
ment and testing of effectiveness measures because these measures are
crucial to the rest of the process, because most staff want to contribute
to this part of the analysis, and because there are so many measures of
effectiveness.
Data collection continues for the duration of the program in order to
gain a complete and accurate picture of program costs, effectiveness,
and benefits.
Data Analysis After data collection starts for each set of measures, analysis begins.
Cost analysis provides the basis for the subsequent cost-effectiveness
and cost-benefit analyses. Effectiveness and benefits are analyzed in
separate weeks following cost analysis. Then cost and outcome data are
combined for an initial cost-effectiveness analysis (during week 13)
and an initial cost-benefit analysis (week 14). In week 15, monthly anal-
yses of cost, cost-effectiveness, and cost-benefit commence.
Both cost-effectiveness analysis and cost-benefit analysis are useful. Of-
ten, benefit information can be derived directly from effectiveness find-
ings. Deriving benefits from effectiveness measures makes cost-benefit
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Table 1. Sample timetable for cost, cost-effectiveness, and cost-benefit analysis of a
substance abuse treatment program
Steps
Weeks
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1. Identify key players, interest
groups, and a coordinator
2. Assign responsibilities for
each step
3. Tailor this timetable to your
program
4. Develop or refine a reporting
plan
5. Describe program
components and desired
outcomes
6. Choose and test cost
measures
7. Develop and test
effectiveness measures
8. Choose and test benefit
measures
9. Implement regular collection
and reporting of cost
measures
10. Regularly collect and report
effectiveness measures
11. Regularly collect and report
benefit measures
12. Perform first cost analysis
13. Perform first effectiveness
analysis
14. Perform first benefit analysis
15. Perform first cost-
effectiveness analysis
16. Perform first cost-benefit
analysis
17. Perform monthly analyses of
cost, cost-effectiveness, and
cost-benefit
Getting Started
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analysis a straightforward addition to cost-effectiveness analysis. If the
monetary value of your program’s outcomes is relatively easy to derive
from information on program effectiveness, or if direct measures of
benefits are easy to come by, you may want to make the extra effort to
do a cost-benefit analysis in addition to your cost-effectiveness analysis.
Progress
Assessment
In your evaluation of the cost assessment process, there should be reg-
ular reconsideration of measures used, analyses performed, and re-
ports compiled. These reconsiderations are a normal response to
monthly analyses and monthly reports. This is a dynamic process that
continuously produces new information. A response to the reports of
cost-related analyses should include a discussion of ways to improve ef-
fectiveness and benefits while reducing costs.
Initial Steps
Identify Key
Players, Interest
Groups, and a
Coordinator
Key players include therapists, program managers, and office staff.
Your funders also should be informed of this project. Interest groups
include patients and their representatives or guardians; the local police
and court systems; the local primary, secondary, and higher education
systems; and public health and other human services in your area.
These groups may have information that you need to measure costs, ef-
fectiveness, and benefits.
The ideal coordinator for this effort may be difficult to find. Although
the program manager or fiscal manager would be a natural coordina-
tor, program politics or funding pressures may require that someone
outside the treatment program coordinate the data collection and anal-
ysis effort. An outside coordinator needs special skills because some
program personnel might see the collection and analysis of informa-
tion on costs, cost-effectiveness, and cost-benefit as an unwarranted
intrusion.
Programs with only a few staff might need to hire personnel for several
hours a week to begin cost analysis and to keep it active until it becomes
a routine part of the program. Larger programs may be able to distrib-
ute this work over their staff. Both small and large programs might con-
sider hiring part-time counselors to reduce new patient load for regu-
lar staff who are assigned responsibilities for the project. Consultants
also may facilitate establishment of cost, cost-effectiveness, and
cost-benefit analyses as part of program operations.
The more people the work is distributed over from the beginning, the
less the burden will be to everyone (and the more likely the project will
keep on track when the inevitable illnesses, vacations, and departures
occur).
Initial Steps
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Assign
Responsibilities for
Each Step
Individuals must be assigned responsibility for each step. A common
mistake is to load too much responsibility on one person, usually the
manager or the coordinator. We suggest that the coordinator only co-
ordinate. Different people should be in charge of the various steps, and
all individuals should report to the coordinator.
Responsibilities for each step are assigned early in the first week. Who
takes which responsibility will depend on the capabilities and work-
loads of program staff.
Tailor the
Timetable to Your
Program
Some programs may not be able to move as fast as suggested in the sam-
ple timetable, and a few programs may be able to move faster. We en-
courage you to adapt this timetable to your own needs and capabilities.
Some flexibility with deadlines also may be necessary; designing mea-
sures and testing them usually uncovers real problems and interper-
sonal and programmatic issues that may take time to resolve.
It is important, once you get started, to revise the timetable to match
your pace. A revised timetable will decrease frustration with missed
deadlines and a schedule that is not feasible. It will also reduce the
chances of abandoning the project.
Develop or Refine a
Reporting Plan
A plan for reporting progress on individual assignments provides a pa-
per trail by which the development of your program analysis can be
tracked. The paper trail makes it easy to pick up tasks if an unexpected
delay arises. It also encourages progress and continued commitment
from everyone.
We recommend that a report be submitted a day before the end of the
week by each person who has been assigned a responsibility. The re-
port should summarize the accomplishments of the week, with appen-
dices providing any proposed instruments and other details. The re-
ports could be reviewed by the coordinator and other key players and
discussed at the end-of-the-week meeting. This is only one of several
possible reporting formats for the earlier steps of the program.
Monthly reports summarizing the weekly reports might be made by the
coordinator to the board of directors or other governing organization.
Setting realistic weekly and monthly goals for progress makes the pro-
cess feasible while sending the message that you expect regular
progress.
Getting Started
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Procedures, Processes, and
Outcomes
Before you can analyze your program, you need to define the outcomes
you are seeking and the program components that contribute to the
patient outcomes. Before you can change your program based on your
analysis, all interested parties must share a common understanding of
what treatment is and what it is trying to do. To that end, it may be use-
ful for the major interest groups to construct a model of the service sys-
tem. The worksheets at the end of the chapter may help you in discus-
sions with program staff and other interest groups.
Cost-Procedure-Process-Outcome Analysis Model
Tables 2 and 3 outline a model for cost-procedure-process-outcome
analysis (CPPOA) (Yates 1996). Table 2 shows the basic model in a sim-
ple flowchart with arrows representing which parts of the model influ-
ence which other parts in ongoing treatment. These arrows show the
primary direction of action. Feedback from outcomes back to proce-
dures is characteristic of good program management and could be rep-
resented by a loop from the box “Interim and Long-Term Outcomes” to
“Program Procedures.” There also is a feedback loop between out-
comes and costs: If outcomes are positive, expenditure of additional
resources is justified.
Table 2. Basic CPPOA model
11
Costs (values of
resources used)
Program
procedures
Psychosocial and
other processes
Interim and long-
term outcomes
The CPPOA model in table 3 is more detailed. It lists several possible
measures for each of the major parts of the model. For example, indi-
vidual therapy, group therapy, and health education are listed under
procedures. Measures such as employment and independent living
appear under outcomes.
Treatment programs and therapists have their own theories about
what are and are not the important psychosocial processes to address
in substance abusers; they also have their own treatment procedures
for changing those processes. Because of this, a universal set of pro-
cesses and procedures is difficult to establish for CPPOA. The following
processes and procedures only illustrate how the ideas of processes
and procedure-process relationships can be used to understand, evalu-
ate, and improve a treatment program. You will want to select your
own procedures and processes to describe your program.
Procedures, Processes, and Outcomes
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Table 3. Detailed CPPOA model
Costs (values of
resources used)
Program
procedures
Psychosocial
processes
Other processes
related to:
Interim
outcomes
Long-term
outcomes
Temporal Individual Skill acquisition Client Relations with Continuation of
Direct service therapy Self-control characteristics Peers interim outcomes
Paid With therapist Social Age Children
Volunteer Medical Job-seeking Gender Spouse/mate Cost savings in
Administrative Vocational Race Relatives Health services
Other indirect Group Relapse Prior treatment Employer Mental health
MIS therapy prevention Employment Others services
Women’s Physically Welfare
Material Men’s Expectancies challenged Employment Employee
Equipment Prevocational Self-efficacy Medical Assistance
Direct service Relapse Outcome complications Independent Program
Indirect prevention Compliance Psychological living operation
Supplies Difficulty of complications Training of new
Medicines Education treatment Cessation of employees
Psychometric Drug abuse Therapist substance abuse
tests Health and Relationships and characteristics Preferred drug Benefits accrued
Office nutrition social support Training Other drugs Tax revenues
supplies Therapist Experience Positive
Referrals Family History HIV transmission modeling
Spatial Health Peers Age behaviors for others
Direct service Social services Employers Gender
Administrative Legal aid Spouse/mate Race Physical health (Prevention)
Other indirect Vocational Others Improved
Addiction Mental health family
Transportation Extra-program physiology and social
Communications climate
Financing
Procedures
The major procedures used in providing substance abuse treatment to
patients include—
 Individual counseling.
 Group counseling.
 Acupuncture.
 Pharmacotherapy.
 Education about human immunodeficiency virus and sexually
transmitted diseases.
 Vocational counseling.
Dividing your treatment program into specific procedures is one of the
most important steps in your cost-effectiveness analysis. These are the
activities that you will later decide to retain, to enhance, to diminish, or
to drop altogether. For this purpose, we suggest that you consider at
least four different treatment procedures. For manageability, however,
do not record more than 15 or 20 procedures.
It is especially important to consult with direct service staff when defin-
ing program procedures. As a first step, consider what sets of actions
make separate contributions to patient outcomes. For instance, it
seems likely that individual counseling and group counseling make
separate contributions.
Definitions are needed for each procedure. The definitions should be
clear enough that program staff can reliably agree when one procedure
or another is being performed. Some procedures (such as individual
counseling) will be easier to define reliably than other procedures
(e.g., confrontational counseling). Specific program components
should also be defined. For example, a confrontational group may be
defined as a therapeutic intervention where 8 to 12 patients address an-
other patient on inappropriate behavior in a group setting facilitated
and monitored by one or more counselors.
Your cost-related analysis will be most useful if the procedure defini-
tions used in your program also correspond closely to procedures used
in similar programs. A publication by the Center for Substance Abuse
(Crowe and Reeves 1995) defines treatment modalities and program
components for substance abuse programs. For instance,
pharmacotherapy is typically defined as a treatment using approved
medications to reduce substance abuse.
Most procedures can be divided into more specific procedures. There
are many types of individual counseling, for example. If reflective,
Procedures
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analytic, behavioral, and other types of counseling are practiced in your
program and contribute to program outcomes to different degrees,
you probably should establish each form of counseling as a separate
procedure. Some programs use confrontational as well as supportive
and educational forms of group counseling, which also can be denoted
as different procedures.
Also, if different staffing levels or qualifications are necessary for some
procedures, those procedures should be considered separately (be-
cause their costs will probably differ). For instance, if a feelings group is
facilitated by a paraprofessional while a psychotherapy group is con-
ducted by a licensed psychologist, these two types of groups should be
considered separately.
The defined procedures should be all-inclusive; when considered to-
gether, they should constitute the entire program. To do this, you may
need to add to a list of specific therapeutic procedures a catch-all cate-
gory such as “other treatment activities.” Be sure, however, that this cat-
egory does not become a dumping ground. It should include only pro-
cedures used one time or infrequently.
Processes
The same treatment procedures work for some people but not others
because a moderating process either facilitates or inhibits the impact of
treatment procedures on outcome. A process internal to the patient
can be created or encouraged by treatment procedures. For example,
some counselors believe that personal growth and responsibility are
crucial processes that treatment must foster. Other processes internal
to the patient may be targets of treatment procedures designed to blunt
or even eliminate them. For instance, some treatment procedures at-
tempt to reduce self-destructive impulses and highly selfish, manipula-
tive processes in patients.
Therapists often believe that outcomes are the product of changes in
patient processes that are themselves the product of treatment proce-
dures. Unfortunately, we cannot assume that these processes are the
ones that were at work. The outcomes of treatment could have been
due to entirely different processes. Also, the procedure could have
changed different processes than those intended. The processes that
actually were changed may or may not have then produced the
outcomes.
To get a clearer picture of which links are active between procedures
and processes, and between processes and outcomes, you need to
measure the procedures, the likely processes changed by those proce-
dures, and the targeted outcomes.
Procedures, Processes, and Outcomes
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The most important processes to measure are those that counselors
and other treatment providers believe to be the crucial determinants of
program outcome. In some cases, these will correspond to psychologi-
cal or other processes for which reliable instruments have been devel-
oped. In other cases, the processes active in the patient that determine
whether treatment succeeds or fails may have to be measured by instru-
ments you develop.
The first step in selecting or developing instruments to measure pro-
cesses is to ask therapists to explain their theories of what processes
need to occur for treatment to succeed and what other processes can
prevent this. The following sections discuss common processes in-
volved in substance abuse treatment.
Psychological
Disorders
Because persons who have psychological disorders may be more likely
to abuse substances, psychological problems are addressed in most
substance abuse treatments. Mental illness is more common in sub-
stance abusers than in nonsubstance abusers according to a number of
studies (e.g., Ross et al. 1988).
The presence of psychological problems may moderate the impact of
treatment. The problems may impede treatment or, if psychological
processes are at a severe phase at the beginning of treatment, more
rather than less improvement may result (Friedman and Glickman
1987).
Some treatment providers hope that reducing negative mental pro-
cesses will subsequently reduce or stop substance abuse. Common
psychological disorders in substance abusers that may be the focus of
treatment procedures include—
 Antisocial personality disorder.
 Phobias.
 Psychosexual dysfunction.
 Major depression.
 Dysthymia (moderate depression).
Other
Biopsychosocial
Processes
Some substance abuse programs believe that one or more of the fol-
lowing processes within the patient must change to achieve outcome
goals:
 Expectancies of reinforcement or punishment
 Certain attitudes and belief systems
 Destructive or self-centered interpersonal dynamics
Processes
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These treatment programs believe that psychological, social, and per-
haps biological processes must be changed before patients successfully
and permanently cease substance abuse.
Readiness to
Change
Yet another way to conceptualize the biopsychosocial processes in-
volved in substance abuse cessation is to say that the processes that
need to be addressed by treatment procedures are determined by how
ready the patient is to change. This approach to understanding the pro-
cess of change says that most patients are, at any moment in treatment,
in one of several distinct stages of increasing readiness to change. To
move the patient to the next stage, certain biopsychosocial processes
need to occur. These crucial processes are evoked by specific treatment
interventions or procedures. The different processes necessary for
transition between stages may require different treatment procedures
(DiClemente 1993; Prochaska and DiClemente 1986).
Procedure-Process Links
The next step is to define the specific relationships between the treat-
ment procedures and the processes they are designed to either encour-
age or discourage. Asking for all the procedure-process links also pro-
vides a check on the completeness of the process list. If some proce-
dures remain for which no processes are specified, either additional
processes need to be described or the procedure may be unnecessary.
Table 4 gives a sample matrix of a program’s processes and procedures.
The cells of this matrix indicate each possible combination of proce-
dures and processes in the treatment program. The cells in the table are
filled in with numbers indicating the strength of the relationship be-
tween each procedure and each process. Working with the program
staff to specify the procedure-process links helps build a better
cost-procedure-process-outcome model that is easier to analyze later.
It is extremely important to be very tactful when you ask therapists for
information or suggest changes. Most treatment providers develop
their procedures for substance abuse treatment over long periods of in-
tense training. They have accumulated considerable experience in and
wisdom about what works for which patients, how well, and when. It is
important to work with the staff to find the best way to describe the
presence, strength, or absence of critical psychosocial processes. These
descriptions usually lead to methods of measuring the processes.
Tailor Procedure-
Process Links to
Your Setting
Suppose, for example, that the majority of counselors at a clinic ex-
press a firm belief that substance abuse is caused by (a) a strong desire
to escape a deplorable situation, (b) a reluctance to face adult responsi-
bilities, and (c) a wish to harm or kill oneself. Moreover, suppose that
Procedures, Processes, and Outcomes
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these counselors believe that, for the patient to cease and maintain ces-
sation of substance abuse, each of these causes must be moderated or
worked around while abstinence is maintained. Your task, then, is to
find or develop measures of processes (a), (b), and (c) above. The
counselors also should be able to specify the treatment procedures that
they use to address processes (a) through (c), so you can help them
measure the occurrence of each procedure for each patient.
Process (b), a reluctance to face adult responsibilities, might produce
the following list of results that counselors expect their procedures to
yield:
 Patient keeps treatment and other appointments.
 Patient does not miss work.
 Patient pays bills on time.
 Patient resolves outstanding legal issues.
The counselors then would identify the procedures used to change the
process: individual counseling, daily scheduling, monthly budget de-
velopment, and role modeling. The final step is to measure the process.
In this example, a monthly checklist can measure the number of days
missed at work, the number of missed appointments, the number of
bills paid, and so on—all signs that the desired process is occurring.
That documentation charts the patient changes related to the process.
Procedure-Process Links
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Table 4. Sample procedure x process matrix
Procedures
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Group counseling 33 % 33 % 33 %
Relapse prevention 20 % 20 % 20 % 20 % 20 %
Individual counseling 50 % 50 %
Case management 75 % 12.5 % 12.5 %
Outcomes
Measuring the impact of treatment procedures is key to analyzing and
improving cost-effectiveness and cost benefits. While the primary out-
come desired by all substance abuse treatment programs is total, per-
manent abstinence from illicit drugs, achieving that goal requires pa-
tients to make many major changes in lifestyle, attitudes, friends, skills,
and so forth. A patient who has not made the necessary adjustments to
a drug-free life has a high probability of relapse.
These changes thus become desirable outcomes in themselves. Some
programs may consider them interim outcomes while others may see
them as final outcomes. Choosing which outcomes represent success
in a substance abuse treatment program depends greatly on the theo-
retical basis of the treatment approach.
Objective
Effectiveness
Measures
Outcome measurement has a relatively long history in substance abuse
treatment. The focus has long been on “real results” rather than on
measures that seem indirectly related to the problems that initiated
treatment in the first place. Such objective measures of effectiveness
include—
 Biological measures of drug use: analyses of urine, blood,
breath, hair.
 Biological measures of infections related partially or fully to drug
use: HIV tests (negative or positive, and immune system cell
counts), hepatitis status, sexually transmitted disease infection
status.
 Criminal convictions, arrests.
Objective measures are important because their validity is high, as is
their acceptance by a broad range of interest groups. It is therefore cru-
cial for treatment programs to collect objective measures, whether they
are the ultimate goals of substance abuse treatment or the means to
other ends.
Subjective
Effectiveness
Measures
Certain interest groups believe that subjective measures are unimpor-
tant. For example, a questionnaire designed to tap an individual’s level
of maturity or personal development strikes some funders as rather dif-
ferent from what “really counts”—the number of assaults and thefts
committed during or after treatment. Nevertheless, many therapists,
patients, patient associates, and researchers are concerned with such
measures of treatment effectiveness as—
 Self-reports of illicit drug use.
 Self-reports of alcohol and tobacco use.
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 Productivity on the job.
 Depression, anxiety.
 Patient functioning in different areas, such as family living, em-
ployment, education.
 Physical health.
 Psychological well-being.
Each program must define its goals for patients in ways that can be mea-
sured. Most of these will be improvements along a continuum. Some
may be staff estimates of change. Whenever possible, objective or exter-
nal measures should be used; staff reports may be perceived as biased
in favor of the program.
Benefits Objective monetary benefits of substance abuse treatment include the
following:
 Financial records from accountants, funders, and tax agencies of
legal employment during and after, versus before, substance
abuse treatment.
 Records of welfare benefits paid during and after, versus before,
substance abuse treatment.
 Records of public health services used during and after, versus
before, substance abuse treatment.
 Records of funds spent on arrests, convictions, and other interac-
tions of the patient with the criminal justice system during and
after, versus before, substance abuse treatment.
Process-Outcome Links
Individual processes can also be linked to outcomes for a more refined
analysis of your program effectiveness. Table 5 shows a sample matrix
with the estimated contribution of each process to each outcome.
Processes Versus
Interim Outcomes
As you work with program staff to define outcomes and processes, you
may find that overall outcomes are easy to define (e.g., permanent ces-
sation of all addictive behaviors), but that many intermediary outcomes
are being proposed (e.g., recovery from a brief relapse). There is a
point at which processes stop and outcomes begin. Events occurring
inside the patient, whether psychological or biological, usually are pro-
cesses. Events occurring outside the patient usually are outcomes.
For example, enhanced self-efficacy for substance abuse cessation may
be the result of treatment procedures, but it is rarely an end in itself.
Process-Outcome Links
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Self-efficacy for substance abuse cessation is enhanced by treatment
procedures as a means to an end—permanent cessation of substance
abuse.
Treatment programs may put certain outcomes before others. These
intermediary outcomes may include patient compliance with a regi-
men of weekly counseling sessions, daily methadone maintenance, le-
gal employment, or a combination of these and other outcomes. These
outcomes occur outside the patient and are themselves the result of
changes in processes (e.g., expectations of rewards for compliance
with the regimen). They are intermediate or interim outcomes, how-
ever, because they are not the outcome for which treatment is designed
and funded. That ultimate or final outcome is cessation of drug use.
Interest Group Differences
Sometimes, one person’s process measure is another person’s final
outcome measure. For certain researchers, therapists, and patients, the
goal of treatment is to change the patients’ internal state—to make
them mentally and physically healthy. For other interest groups, in-
cluding much of the tax-paying public, mental and physical health are
intervening processes at best. For these interest groups, the goals of
treatment are to get patients off drugs, to keep them off drugs, to stop
them from committing criminal acts, and to help them become net ben-
efits rather than net costs to society.
A potentially useful strategy for dealing with interest groups advocating
Procedures, Processes, and Outcomes
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Table 5. Sample process x outcome matrix
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Drug free (complete abstinence)
40 % 100 % 25 % 32 % 10 %
Stable employment
20 % 25 % 80 % 4 % 40 %
Crime free (avoidance of all
criminal behavior)
40 % 25 % 32 % 10 %
Compliance with probation
and parole
25 % 20 % 32 % 40 %
different procedures, processes, and outcomes is to acknowledge the
importance of each measure and to structure the analyses so that all
measures are included. Some analyses can show how well different
treatment procedures produce the different process measures. Addi-
tional analyses can find out how well the same procedures produce the
various outcome measures. Further analyses can see whether there was
a relationship between producing the process measures and attaining
the outcomes.
For example, the extent to which different treatment procedures im-
proved patient functioning, patient health, and patient depression and
anxiety can be tested in one set of analyses. Another set of analyses can
examine how different treatment procedures affected patient use of
drugs, criminal acts, and job productivity.
Using the Worksheets
The following worksheets are provided to help you develop a model of
your program—what it does, how it does it, and the outcomes it ex-
pects to produce. Working with all interested parties and staff mem-
bers is important to assure that everyone has the same concept of the
program and the same perspective on proposed changes.
Resources To make a complete list of the crucial resources invested in treatment
(worksheet A) and to assess their value (their cost) accurately, ask dif-
ferent interested parties what they contribute to treatment and the
value of those contributed resources.
After the list of procedures is available, you can check the completeness
and accuracy of the resource list by mapping resources onto proce-
dures. Make sure that there are sufficient amounts of each type of re-
source listed to put each of the procedures into effect. Worksheet B can
facilitate this cost-procedure mapping and the review for completeness
and accuracy.
Procedures Procedures can be classified by theoretical perspectives or by the par-
ties responsible for delivering the procedures. The latter generally pro-
vide a more concrete list of what was done to whom, by whom, and
when.
Just as many interest groups may need to be consulted to obtain a com-
plete and accurate list of resources that make treatment possible, a vari-
ety of parties may take part in the delivery of procedures that facilitate
patient recovery and other outcomes (worksheet C).
Using the Worksheets
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Processes This part of the service system model often is the most challenging to
construct. Direct service providers, such as counselors, aim their treat-
ment procedures at a variety of processes internal to the patient. Be-
cause these processes are difficult to observe or detect with psychologi-
cal tests and other measures, serious disagreements may result about
what is being changed by treatment procedures. Providers’ strong be-
liefs in their own favorite treatment procedures may further complicate
discussion of procedures and procedure-process-outcome linkages.
A minimal check on the completeness of the process list (worksheet D)
is possible. Each procedure listed earlier should be targeted at one or
more processes. If a procedure exists for which no process can be
named, it is likely that another process needs to be made explicit. If a
process exists for which no treatment procedure is identified, the pro-
cess may involve community economics or politics. If, however, a cru-
cial process is identified for which no procedure is present in the treat-
ment program, introducing a procedure for this process could result in
superior outcomes. Worksheet E can facilitate this procedure-process
checking.
Another way to check on the completeness of the process listing is to
make sure that there is at least one process mapped to each outcome
(worksheet F).
Outcomes You may wish to distinguish between interim and long-term outcomes.
You also may find it useful to list separate outcomes that are and are not
monetary. Of the outcomes that are not monetary, you also may want
to distinguish between those that can and cannot be readily monetized
(worksheet G).
CPPOA Model To help describe your program, summaries of direct cost-outcome rela-
tionships may be useful. Worksheet H can be used to make this analysis
easier.
The preceding analyses need to be integrated, so that the links between
resources and procedures, procedures and processes, and processes
and outcomes can reveal the most cost-effective and cost-beneficial
path to outcomes. The steps and diagrams in worksheet I can help you
settle on several ways to improve the outcomes and/or reduce the costs
of your program.
Summary
You may not be able to collect detailed information on all the psycho-
logical, social, and neurological processes that can moderate relation-
ships between procedures and outcomes. You may barely have room
Procedures, Processes, and Outcomes
22
and time to record basic demographic characteristics of patients, such
as gender, race, and age, that may influence procedure effects. Even if
you cannot measure and analyze each cost, procedure, process, and
outcome variable that might be important, thinking and talking about
them sometimes can set the stage for systematic improvement of pro-
gram outcomes within cost constraints. These discussions also help
you identify what procedures and processes make up your program. A
clear understanding of what your program really is, how it works, and
what changes it can prompt is essential in making decisions about pro-
gram changes.
Summary
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Worksheet A. Resources used in treatment
Temporal (personnel)
Temporal (client, other)
Spatial (facilities)
Material
Communications
Financing
Liability
Other
Summary
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Worksheet B. Resource-procedure analysis
1. List the procedures that seem essential.
2. List the resources that enable those procedures.
3. Estimate the strength of the relationships between each resource and each procedure.
Procedures 
Resources

If you collected data on these resource-procedure relationships, which would you expect to be
strongest, be weakest, need more information?
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
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Worksheet C. Procedures implemented
by treatment
Initiated or directed by:
Therapists
Patient’s family
Patient
Employers
Other change agents
Worksheet D. Processes experienced by
patients, possibly as the result of
treatment procedures
Psychological: Cognitive
Psychological: Affective (emotional)
Psychological: Behavioral
Dyadic (with one other person)
Social
Biological
Other processes
Summary
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Worksheet E. Procedure-process analysis plans
1. List the psychological, social, biological, and other processes that seem essential.
2. List the procedures that enable those processes. (This is expected to be a subset of the procedures
listed earlier.)
3. Estimate the strength of the relationships between each procedure and each process.
Processes 
Procedures

If you collected data on these procedure-process relationships, which would you expect to be
strongest, be weakest, need more information?
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
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Worksheet F. Procedure-outcome analysis plans
1. List the outcomes that are most important.
2. List the processes that enable those outcomes.
3. Estimate the strength of the relationships between each process and each outcome.
Outcomes 
Processes

If you collected data on these process-outcome relationships, which would you expect to be
strongest, be weakest, need more information?
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
Summary
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Worksheet G. Outcomes produced by processes
Interim
Long-term
Monetizable or monetary benefits
Nonmonetizable outcomes
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Worksheet H. Resource-outcome analysis plans
1. List the outcomes that seem essential.
2. List the resources (costs) that make those outcomes possible.
3. Estimate the strength of the relationship between each resource and each outcome.
Outcomes 
Resources

If you collected data on these resource-outcome relationships, which would you expect to be
strongest, be weakest, need more information?
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
Summary
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Worksheet I. Resource-procedure-process-outcome analysis plans
1. Using the blank CPPOA model on the next page, list resources, procedures, processes, and out-
comes that still seem essential.
2. Use lines to connect those resources and procedures, procedures and processes, and processes and
outcomes that represent the enduring, crucial links between the components of your service sys-
tem. Summarize these linkages.
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
3. Estimate the strength of the relationships by darkening the connecting lines that represent the
strongest relationships. Which relationships are strongest and on which do you need more
information?
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
4. Working backward from outcomes, identify the critical, causal paths for the process-outcome, pro-
cedure-process, and resource-procedure linkages. Describe this critical path:
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
5. Examine the strong relationships that are not now on the critical path. Could programmatic change
add these relationships to the critical path?
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
32
W
o
rk
s
h
e
e
t
J
.
C
P
P
O
A
M
o
d
e
l
C
o
s
ts
(v
a
lu
e
s
o
f
re
s
o
u
rc
e
s
u
s
e
d
)
P
ro
g
ra
m
p
ro
c
e
d
u
re
s
P
s
y
c
h
o
lo
g
ic
a
l
p
ro
c
e
s
s
e
s
O
th
e
r
p
ro
c
e
s
s
e
s
re
la
te
d
to
:
In
te
ri
m
o
u
tc
o
m
e
s
L
o
n
g
-t
e
rm
o
u
tc
o
m
e
s
Overview of Costs
Cost: 1. An amount paid or required in payment for a purchase; a price.
2. The expenditure of something, such as time or labor, neces-
sary for the attainment of a goal.
The American Heritage® Dictionary of the English Language,
Third Edition © 1992
The first definition of cost above is what most people use when they
start planning for a cost-related analysis. The second definition, how-
ever, is more useful because it allows for a much broader and more ac-
curate accounting of the efforts necessary to change behavior. The
amount of money paid, reimbursed, or requested for reimbursement
for drug treatment varies depending on the national and local eco-
nomic climate, the rate of inflation, and many other factors. To gain an
accurate picture of costs, we must look beyond the simple lump sum
totals allocated for a program.
Although accounting records for cost assessment are useful in figuring
costs, they usually do not supply the information needed to determine
all expenditures. This manual shows how to figure costs once cost data
have been collected and describes strategies for collecting information
on the specific costs of treatment.
Cost Measures
When used in most treatment programs, cost, cost-effectiveness, and
cost-benefit analyses are more complicated than in business because
the money spent for treatment rarely is a complete and accurate mea-
sure of total treatment costs. To truly understand how a program oper-
ates and to find ways to improve its outcomes and reduce its costs, all
the resources it uses need to be described and related to outcomes.
Basic Cost
Categories
In choosing and recording cost data, it is helpful to categorize expendi-
tures. Most treatment programs pay for—
 Treatment personnel (such as counselors, nurses, physicians,
social workers, and psychologists).
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 Administrators and office personnel (including managers,
human resources, and payroll).
 Space.
 Furniture.
 Equipment.
 Transportation.
 Communication services (including telephone, e-mail, and
Internet services).
 Vendor services (including drug tests, accounting, security).
 Insurance (including professional liability) and finance (includ-
ing costs of corporate accounts).
Donated Resources Volunteered time and services, donated facilities, space shared with
other programs for which the treatment program may pay little or no
cost, and donated equipment, supplies, and other resources rarely
show up in a program’s accounting records. These donated or under-
valued resources, however, may be crucial to program operations.
“Free” resources and their value need to be included in comprehensive
descriptions of program costs.
Although programs should not be penalized for obtaining services,
space, and other resources without having to pay money for them, it
would not be accurate to say that a program cost $80,000 when an addi-
tional $20,000 of time, space, equipment, and supplies went into treat-
ing patients. It also would be difficult to replicate a program unless all
the resources it used—including those volunteered by the commu-
nity—were included in program descriptions.
Indirect Costs Indirect costs, such as overhead, or shared costs must also be included
to give a fair assessment of your program. This is particularly important
in figuring costs of a single program in a much larger organization, such
as the hospital detoxification component of a multiprogram organiza-
tion where the fiscal and medical directors may be shared across
components.
The Need for Cost per Patient
Determining all of the costs for your program, both paid and unpaid, is
relatively simple, and you probably categorize them to some extent al-
ready. However, to evaluate your program, you need to consider your
costs at the level of the individual patient, not just the treatment pro-
gram as a whole. Although some programs also aim their interventions
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at the family and the community, if the primary focus of treatment is on
the substance abuser, then the primary focus of measurement should
also be on the substance abuser.
A simple approach to finding the cost per patient is to divide the total
cost of a program for a particular period by the total number of patients
the program treats during the same period. This calculation assigns the
same cost to treatment for each patient, no matter how many or few
program resources were devoted to treatment of the patient. The prob-
lem is that not all patients use the same amount of resources. Some use
more, a few use a lot more, and many use less.
Most programs tailor treatment to the needs of each patient, and most
patients use treatment resources to different degrees. For example, pa-
tients may show up for some but not all appointments. Some patients
also leave treatment after the first or second contact, whereas others
stay throughout the period (e.g., a month) during which costs are as-
sessed. All of these factors make the cost per patient different for differ-
ent patients.
In addition, the outcomes or behavior change associated with the re-
sources expended varies. Some patients change a lot with a lot of re-
sources, some change a little with a lot of resources, and a few change a
lot with a few resources. To analyze cost-effectiveness and cost-benefit
accurately, cost as well as effectiveness and benefit must be measured
separately for each patient.
Standardized Costs
Using someone else’s estimate of treatment costs is not advised. Some
standardized treatment costs are not specific enough. To improve the
cost-effectiveness and cost-benefit of treatment by adding or dropping
treatment procedures, the cost of each procedure needs to be known.
Because standardized cost estimates do not always list costs of specific
procedures, it would be difficult to determine whether the effective-
ness of a procedure justified the cost.
Procedure costs also need to be measured separately for each patient.
Costs of performing the same basic procedure may vary between pa-
tients according to patient age, substance abuse history, and many
other factors. The cost of individual therapy may be the same for each
patient if the provider and the duration and number of sessions are all
dictated by a third party. Even within highly standardized treatment de-
livery systems, however, patient participation (and thus resources actu-
ally used) will vary significantly and thus affect cost.
Also, most standardized treatment costs are not broken down by type
of resource. For example, Anderson and associates (in press) provide
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detailed cost statistics for a variety of treatment procedures at several
levels of specificity. The amount and value (cost) of each resource that
made the procedure possible is not, however, mentioned. Information
on the types and amounts of resources currently used can be especially
valuable when trying to decrease costs while maintaining program out-
comes. For example, it may be possible to implement the same proce-
dures (e.g., individual therapy) using less expensive resources (e.g.,
paraprofessional counselors instead of clinical psychologists) while
achieving similar outcomes. A breakdown of treatment procedure
costs by type of resource could help managers decide what substitu-
tions might be possible with minimal impact on outcomes.
In addition, standardized estimates of treatment cost may not be
generalizable to your program. Different regions, even different parts
of the same city, have vastly different economic and professional envi-
ronments, which affect cost in complex ways.
Finally, measuring costs for specific procedures can generate useful in-
sights into program operations. Recording how one spends time in dif-
ferent treatment-related activities may have a positive effect on one’s ef-
ficiency in those activities. In fact, it is a good idea to collect cost data for
a week or two before starting to collect the cost data that will be used in
CPPOA, because those data may change as habits are modified.
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Collect Cost Data
Personnel Costs
Typically, personnel accounts for the largest segment of program costs.
Finding the personnel costs of treating each patient involves two basic
tasks:
 Measuring the cost of services provided directly to the patient
(direct service). Direct service personnel are counselors, social
workers, nurses, physicians, and psychologists who spend the
majority of their time working directly with patients.
 Dividing among patients the costs of treatment resources that
are not used to treat individual patients but are necessary to run
the program (indirect service). Indirect service personnel typi-
cally are managers, clerical staff, maintenance workers, accoun-
tants, and others who do not usually work directly with patients.
The distinction between direct and indirect is critical in calculating
costs and may be different for cost analyses than for current billing
practices. For instance, many programs are unable to bill for services
when the patient is not present, such as telephone calls or case plan-
ning meetings with other service providers, even though these activi-
ties may be essential to change patients’ behavior. The resources that
make these potentially crucial procedures possible need to be in-
cluded and measured as direct costs for individual patients.
Direct Service
Personnel
Time spent by personnel providing services to a patient is a cost that
can be assigned immediately to that patient. This includes time
spent in direct contact with the patient (e.g., during a counseling
session) and time spent doing other things for that patient (e.g., call-
ing an attorney who is arguing the patient’s case or meeting with a
supervisor about the patient).
Because different program personnel may have their time valued dif-
ferently, receiving different salaries or wages, you need to collect this
information in terms of hours; the data are translated into dollars at a
later stage.
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Each member of the staff should complete a daily timesheet recording
time spent by patient and by activity. Activities include direct patient
services subdivided into specific procedures, direct services on behalf
of individual patients, and indirect services in support of the program.
Other Direct
Services
All patient contacts should be recorded as direct costs for that particu-
lar patient. However, not all contacts are treatment. For example, in-
take interviews, screening, and psychological testing, which may in-
volve direct service staff, are not treatment procedures. Such activities
are used with all patients regardless of treatment procedure and are
not directly related to patient outcome. This time should be recorded
on the timesheet under the appropriate activity and patient codes.
Indirect
Services
Indirect service activities, such as doing paperwork, attending meet-
ings, or participating in training workshops, also need to be recorded
by direct service staff. Specific categories of indirect services are only
necessary to track if you want to analyze the costs of those services
separately. Otherwise, a simple “indirect services” category should
suffice.
Indirect Service
Personnel
Time spent by personnel in activities related to the operation of the
program, but not related to treatment of individual patients, needs to
be included in the cost of treating a patient. If the value of this indirect
service time is not included in treatment costs, the real cost of treat-
ment will be underestimated. Activities ranging from weekly staff meet-
ings to mass urine screenings to supervision are essential in maintain-
ing the program and, thus, serving patient needs.
Some staff may have direct contact with patients yet not be involved in
treatment, such as the receptionist or the staff member who collects
urine. The receptionist’s time should probably all be recorded as indi-
rect, but you might consider the time involved in urine collection as a
direct cost for the individual patient, depending on your program.
You can ask administrators and other personnel who provide the bal-
ance of indirect services to record the activities they perform, or you
can simply assign all their work to indirect services, depending on what
costs you are interested in analyzing. For example, you might want to
collect data on the cost of performing your cost analyses.
Some administrators and office staff may split their time between differ-
ent programs, or between treatment programs, research, and teaching
at other institutions. To determine the portion of these individuals’
time and salary that should be allocated to the program for which costs
are being assessed, you need detailed records of how much time the in-
dividuals actually spend in program-related activities. They, too,
should fill out a daily timesheet.
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Volunteers All individuals who contribute to the running of your program should
fill out a timesheet, even if they are not paid. If they provide assistance
that you would otherwise either pay someone to do or be forced to cut
back on your services, they should record their time. This includes in-
terns, community volunteers, family members, and in some cases,
patients.
Other Direct Patient Costs
Space The second largest cost of a program is payment for (or the equivalent
cost of) working space. This cost should also be allocated by patient.
Simply dividing the total cost by total number of patients does not give
an accurate measure. Rather, the time that a given space (say, a coun-
selor’s office) was used for a particular procedure with a particular pa-
tient should be recorded.
Since different rooms and areas of a facility differ in size (and therefore
in cost), it will be necessary to also specify which office or room was
used. If offices are all the same size, `office’ would be sufficient desig-
nation. If offices vary appreciably in size, it may be necessary to use cate-
gories like `office 1,’ `office 2,’ and so forth. Rooms for group meetings
could be designated as just that, and other spaces could have similar us-
age definitions.
Other Resources To the extent that administering a specific treatment procedure to a
particular patient involves expenditure of resources other than person-
nel and space, the amount of those resources spent should be recorded
for that patient. This is especially important for resources that may vary
between patients in ways not proportional to the amount of direct ser-
vices they receive.
For instance, it is conceivable that some patients but not others would
be transported to the substance abuse treatment and related programs.
Patients also may differ in how much it costs them to get to and from
your program.
It is possible that some other categories of resources, such as medical
supplies or communications expenditures, are used more for some pa-
tients than others. Naltrexone or methadone, for example, might be
used for some patients and might vary between those patients in dos-
age amount and frequency. Similarly, telecommunications charges
might be higher for patients who live farther from the clinic, or who re-
ceive remote treatment procedures such as therapy contacts via phone
or over Internet connections. Petty cash expenses and assistance pro-
vided to patients also may differ dramatically between patients.
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Vendor services also may be prescribed for some patients and not oth-
ers. Consider, for example, the need for some patients to have uri-
nalyses that detect not just presence or absence of drug metabolites but
concentrations that allow estimates of time since last substance use.
Know When to Stop
Enumerating Direct
Service Costs
At some point, one has to stop listing specific costs and let them be part
of the overhead cost. Although there are no hard and fast rules for de-
termining this point, cost accounting should not become so cumber-
some as to lead to staff rebellion. If a cost cannot easily be entered on a
standard form by the person performing that service, it may not be
worth recording.
Forms and Formats
Personnel Time Measuring who provided what services to which patients for how long
should be done soon after the service is provided to preserve accuracy.
Most programs already record this information for licensing or accredi-
tation. Much of the cost data needed for cost-effectiveness and
cost-benefit analysis can be derived readily from information collected
routinely in many service systems. Additional information needed for
specific cost analyses may simply need to be added to existing forms.
Ultimately, the information needs to be recorded on a form that
shows—
 The date and time the service was delivered.
 The patient(s) who received the service.
 The person who provided the service.
 The nature of the service (the procedure).
 The amount of each resource used when providing the service.
A form can be created to remind personnel to record this information.
The form can show a blank for each item that needs to be filled in, as
shown in table 6. This is a service- or procedure-driven form similar to
patient-driven forms used by many programs where services are re-
corded per patient and then kept in patient records. The patient-driven
forms are appropriate for deriving cost data as long as they include the
information above.
Whatever recording method is used, services provided on behalf of a
particular patient when that patient was not present (such as tele-
phone calls, case meetings, and paperwork) should be included with
specific time allocations for each procedure for that patient.
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Table 6. Sample daily timesheet
Name _____________________________________________________Date ____________________________
Time (hours) Patient code Activity code Space code Direct cost (codeand amount) Other
Activity codes: Activity codes (cont) Direct cost codes:
01 Individual counseling 10 Meetings M Medication (list type and
02 Group counseling* 11 Paperwork number of doses)
03 Drug education 12 Supervision T Transportation (list cost if known
04 STD and HIV education 13 Cost accounting otherwise T1 for one-way,
05 Financial advising 14 All other indirect T2 for round trip)
06 Couples therapy P Advances from petty cash
07 Case management Space codes: C Communication services
08 Pharmacotherapy 01 Office 1 V Vendor services
09 Other treatment 02 Office 2 O Miscellaneous ($ amount)
A01 Intake 03 Group meeting room
A02 Assessment
*If group meeting, list below codes for all patients who attended. If more than one group meeting recorded here, identify as
Group 1, Group 2, etc., both in column above and in list below.
__________________________________ __________________________________ _____________________________________
__________________________________ __________________________________ _____________________________________
__________________________________ __________________________________ _____________________________________
__________________________________ __________________________________ _____________________________________
__________________________________ __________________________________ _____________________________________
__________________________________ __________________________________ _____________________________________
__________________________________ __________________________________ _____________________________________
__________________________________ __________________________________ _____________________________________
__________________________________ __________________________________ _____________________________________
__________________________________ __________________________________ _____________________________________
__________________________________ __________________________________ _____________________________________
When paperwork, supervision, or meetings are not related to specific
patients, the activity code would be entered with no patient code. To
ensure that the patient code was not omitted through oversight, pa-
tient code 000 could represent “not patient related” on timesheets for
direct service providers.
Codes should be created for all indirect activities of interest to the pro-
gram, such as staff meetings, training, community meetings, site prepa-
ration, financial report analysis, and administrative meetings. If you do
not expect to analyze the costs or benefits of specific indirect activities,
do not burden staff with unnecessary time breakdowns.
A good pilot-test of time recording is essential. Ask for extensive staff
feedback on ease of use, activities selected, clarity, and relevance.
Other Expenditures The amount of each resource expended when providing direct services
to each patient may have to be recorded according to Federal law (e.g.,
methadone dose). Other resources, such as patient transportation or
long-distance phone use, may not be recorded by accounting or billing
procedures in a way that allows expenditure of the resource to be
traced back to a particular counselor, procedure, or patient. Where fea-
sible, these expenses should be recorded on the timesheet of the per-
son performing the service or authorizing the expenditure.
In some cases, it may be easier to use a separate cost-tracking form (ta-
ble 7). The results need to be entered in separate rows for each re-
source and in appropriate columns for procedures and patients. If a re-
source such as transportation enables several procedures, such as indi-
vidual therapy and HIV/STD education provided during the same visit
to the program, that resource should be distributed among the proce-
dures according to the relative cost of the other resources spent on
those procedures, such as counselor time. In some cases, depending
on the proposed level of analysis, it may suffice to divide a cost such as
transportation equally among associated procedures.
Other Forms Although forms on paper or computers are the most common methods
of data collection, your staff may find it more convenient to record es-
sential cost information by speaking into a tape recorder.
Mark-sensitive forms also can be developed and used to record and in-
put information quickly.
Some human service programs have had success with bar code readers.
A wand or small card is moved over different bar code patterns to re-
cord the date, time, patient, service type, service duration, and other in-
formation. The wand inputs the codes directly into a computer. The
card can store one or more days of information for later downloading
to a computer. Personal information managers (PIMs) or personal
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digital assistants (PDAs) also can be programmed to prompt staff to re-
cord information about program activities and to transfer those data to
computers at the end of the day.
Electronic forms can be filled out on a computer and then sent to a
spreadsheet file or other cost information data base on the computer
network. These “on-line forms” allow information to be communicated
directly from the service provider to the computer data base. You may
want to store this information in a temporary file and review it for accu-
racy and completeness before depositing it in the cost data base.
Train Staff to Record Data
Once the recording forms have been developed, pilot-tested, and
adapted, staff must be trained in their use. This important step is fre-
quently skipped because of time pressures and because the forms may
appear self-explanatory. Too often, however, the information to be en-
tered can be interpreted in many ways. To ensure that the information
recorded is the same across all staff, take the time to train staff on how
to use forms and what is to be recorded. Remember to also train all
new staff members and volunteers as they enter your program.
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Table 7. Sample cost recording form
Cost code Amount Patient code Activity code Explanation
If a single cost applies to more than one patient or more than one activity, please list all appropriate codes in same row as
the amount.
Ensure Complete Data Collection
The forms above tell you what information is needed but not exactly
how to get it. Although some people are conscientious about complet-
ing and turning in forms on time, others avoid or neglect the task.
The following sections present strategies for ensuring a steady flow of
complete and accurate cost information. Similar strategies may be
needed to obtain information on program effectiveness and benefits,
although the providers of that information are more likely to be
patients.
Assign Daily
Deadlines
Experience has shown that simply giving providers forms does not pro-
duce a high rate of return. Providers often forget to fill out the forms or
they leave them until the end of the week or month. The delay usually
results in guesswork and haphazard form completion just before the
deadline.
To produce a high rate of form return, allow time daily for record com-
pletion and require that the forms be submitted before the providers
leave work. In addition, a supervisor needs to check forms on an ongo-
ing basis (daily, preferably). Accurate and timely data are key to passing
an audit, passing a license review, withstanding a liability claim, and
conducting cost-related analyses. Inaccurate or delayed record com-
pletion should be addressed in staff or supervision meetings.
Validate
Information
Neither completeness nor accuracy is guaranteed, however, by a daily
deadline. Only someone who checks the forms against other service re-
cords, such as clinical case notes, can determine completeness (Did ser-
vices get recorded for all patients who received them?) and accuracy
(Did the amount of services, such as session duration, get recorded for
each service the patient received?). Receptionist records or some other
archive needs to be compared every week against direct service provid-
ers’ timesheets to make sure that the forms are complete.
However, do not assume that timesheets must match payroll records.
Some research has found that highly paid, salaried professionals occa-
sionally spend less time in treatment activities than they are paid for,
while staff on the low end of the pay scale sometimes work many more
hours than they are paid for (Yates et al. 1979).
The individual responsible for combining the data from all personnel
into a monthly spreadsheet or data base would do well to combine the
data weekly. Missing data could then be sought before it is forgotten.
The weekly spreadsheets could be combined into the monthly report
without entailing additional work.
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Motivate Providers One way to motivate providers to submit cost information forms on
time is to make pay contingent on accurate record completion by the
deadline. The program administrator must be willing and able to deny
pay if records are not submitted for work; otherwise, the contingency
will rapidly lose its effectiveness. Another method of encouraging
prompt submission of time records is to insist politely that records be
completed before the provider leaves for the day and to reward staff
who have the highest completion rates.
Monitor
Completeness
and Accuracy
Whoever is in charge of cost data collection could develop tables and
graphs to monitor form completion by providers. These could be used
to give providers weekly feedback, encouragement, and rewards for re-
cord submission.
Two factors could be charted: the percentage of patients for whom the
counselor submitted cost forms on time and the percentage of patients
for whom the counselor submitted forms that were later judged valid
by comparing sessions recorded in clinical notes to sessions recorded
on forms.
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Find the Cost per Resource
per Procedure per Patient
When you have all the records from all direct service providers and you
are satisfied with the validity of these records, it is time to analyze the
cost numbers. The hardest work is done: The data are in! These data are
essential for the cost calculations described in this chapter or for almost
any other approach to allocating the cost of each resource to each treat-
ment procedure.
Establish a Reporting Period
The first step is to determine the period you want to analyze. A week is
probably too short (except for testing your procedures). One month is
a typical period—long enough so that analyses are sufficiently spaced
yet short enough that the accumulated data are not overwhelming.
Transform Direct Staff Time Into Costs
The next step is to gather and organize all the personnel time for the se-
lected period. A spreadsheet of rows and columns, on a computer or a
large sheet of paper, will help you assemble the time data. The sample
spreadsheet in table 8 provides the foundation for calculating costs and
is built on throughout this chapter. The basic premise on all the spread-
sheets is that the greater the detail with which you describe your data
now, the more you will be able to do with the data later.
The sample spreadsheet shows only the first two patients. More pa-
tients and other service providers can be added with additional col-
umns and rows. Most computer spreadsheets can hold hundreds of
columns, many more than can be seen on the screen at one time.
While all the calculations described here can be done by hand, using a
computer spreadsheet, like Microsoft Excel© or Lotus 123© will save
time copying and calculating. Computer spreadsheets make it easier to
transform time data into cost data and to distribute indirect costs over
patients and procedures. Also, once you enter the data into a computer
47
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Table 8. Sample spreadsheet template
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Direct service
providers
Counselors — A
B
Psychologist
Psychiatrist
Social Worker
Physician
Nurse
Other
Indirect service staff
Program director
Office Manager
Receptionist
Accounting assistant
Other resources
Space
Office 1
Office 2
Group meeting room
All other
Supplies
Transportation
Communication services
Vendor services
Insurance and finance
Total direct service
resources
spreadsheet, you never have to enter it again. The information can be
manipulated many times without having to pull out a calculator or
eraser.
Whether on a computer or long sheets of paper, the spreadsheet
should list all resources (in rows), all patients (in columns), and all pro-
cedures (in columns, repeated under each patient’s column). All treat-
ment procedures that are provided at the clinic should be listed under
each patient even though some patients will not receive all procedures.
For example, some might receive drug-free therapy, some might re-
ceive acupuncture, and some might receive methadone, while all
might participate in individual and group therapy.
Separate sets of rows should be made for each type of resource (Direct
Service Providers, Space, etc.). Different direct service personnel
(Counselor X, Counselor Y, Physician Z) should be listed in separate
rows. Different spaces (Office 1, Office 2, Group meeting area) should
be listed in separate rows as well.
Record Hours per
Procedure per
Patient
Direct
Service Time
Working from the forms used to collect time data, add up the numbers
(or fractions) of hours spent by each provider performing each proce-
dure for each patient for the reporting period. Enter this number in the
appropriate cell, that is, where provider, patient, and procedure come
together on the spreadsheet.
For group counseling, where several patients are involved at the same
time, it will be necessary to divide the meeting time equally among the
patients attending the meeting. This can become a little complicated
when some patients skip a meeting or new ones enter, or when the
same group of patients has different co-leaders during the reporting
period. Table 9 gives an example of finding the numbers to enter on
the spreadsheet.
Indirect
Service Time
When indirect time is not broken down into categories, the total indi-
rect time for each staff person for the period is entered in the row for
that person in the total column. This applies to direct service staff, indi-
rect staff, and volunteers. Indirect time that is categorized should be
entered in the appropriate cell.
Continue entering time for all personnel until you have entered all the
information collected for the month.
This is the first step in creating a Resource Use Spreadsheet. It stores the
information others will need to replicate your program. The informa-
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Table 9. Assigning patient and provider time for group meetings per period
Patients 1 through 8 attended the first 1-hour group meeting of the month, led by Counselor X and
Intern C. (1 hour divided by 8 patients for each leader)
Patient 2 skipped the second group meeting, which was led by Counselor X and Intern A. (1 hour
divided by 7 patients for each leader)
Patient 6 and Counselor X had the flu during the third week; the meeting was co-led by Counselor Y
and Intern C. (1 hour divided by 7 for each leader)
Patients 2 and 6 were both absent the fourth week; the meeting was led by Counselor X and Intern
A. (1 hour divided by 6 patients for each leader)
Provider
Patient Total hours
(Do not enter
in
spreadsheet)
001 002 003 004 005 006 007 008
First week
Counselor X .125 .125 .125 .125 .125 .125 .125 ,125 1
Counselor Y
Intern A
Intern C .125 .125 .125 .125 ,125 .125 .125 .125 1
Second week
Counselor X .1429 .1429 .1429 .1429 .1429 .1429 .1429 1.0003
Counselor Y
Intern A .1429 .1429 .1429 .1429 .1429 .1429 .1429 1.0003
Intern C
Third week
Counselor X
Counselor Y .1429 ,1429 .1429 .1429 .1429 .1429 .1429 1.0003
Intern A
Intern C .1429 .1429 .1429 .1429 .1429 .1429 .1429 1.0003
Fourth week
Counselor X .1667 .1667 .1667 .1667 .1667 .1667 1.0002
Counselor Y
Intern A .1667 .1667 .1667 .1667 .1667 .1667 1.0002
Intern C
Monthly totals (enter in Resource Use spreadsheet)
Counselor X .4346 .125 .4346 .4346 .4346 .2679 .4346 .4346 3.0005
Counselor Y .1429 .1429 .1429 .1429 .1429 .1429 .1429 1.0003
Intern A .3096 .3096 .3096 .3096 .1429 .3096 .3096 2.0005
Intern C .2679 .2679 .2679 .2679 .2679 .125 .2679 .2679 2.0003
tion will remain useful to others after monetary cost data have become
obsolete due to inflation or other changes in monetary units.
Record Hourly
Rates
Next, create another spreadsheet, the Cost per Unit Resource spread-
sheet. This spreadsheet is exactly like the Resource Use spreadsheet ex-
cept that instead of time in each cell, it lists the rate per hour for each
staff member for each procedure performed for each patient or for in-
direct activities.
Direct
Service Staff
Among direct providers, this rate may be set by contract at so many dol-
lars per hour. On the other hand, individual rates may be set for differ-
ent procedures performed by the same person. For example, one
counselor might be paid $30 for each hour of individual therapy, $40
for each hour of group therapy, and $35 for each hour of group HIV ed-
ucation. Another counselor with different training might be paid at dif-
ferent rates for the same procedures. If these rates are available, they
can be entered directly into the spreadsheet. Hourly rates for salaried
staff can be computed as shown in table 10.
This cost per unit resource often is the same for each patient, but sliding
scales and peculiarities of providing the same procedures to patients
with different needs may produce different costs per resource unit ex-
pended. These differences should be recorded in the spreadsheet.
Indirect
Service Staff
When staff members are on salary, hourly rates should be calculated
from the annual salary as in table 10. Once computed, these hourly
rates should be entered on the Cost per Unit Resource spreadsheet in
the row for that staff member in the cells for indirect activities
Volunteers Volunteers’ time is a valuable resource that should be included in cost
assessments. Direct service volunteers, such as counselor interns, can
record time spent in program activities in the same way that other di-
rect service providers record their time. The pay rate for their time can
be set at what would be paid if someone with similar education, train-
ing, and background had to be hired to replace the volunteer.
The pay rate for volunteers who provide exclusively indirect service,
such as a patient’s family member working in the office, also can be as-
sessed by what it would cost if a replacement had to be hired to do the
work.
Compute the Cost
of Procedures per
Patient
Once the hourly pay rate for each provider is calculated, it can be multi-
plied by the number of hours spent providing direct service to a patient
to figure the cost of administering each procedure to each patient. This
amounts to multiplying each of the entries in the Resource Use spread-
sheet by the corresponding entries in the Cost per Unit Resource
Spreadsheet and entering these new numbers in a third spreadsheet,
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the Resource Cost spreadsheet that has the same columns and rows as
the other two.
Using computer spreadsheets, it is easy to copy the spreadsheet struc-
ture to create the second and third spreadsheets from the first. (To
make things more convenient, these three spreadsheets can be
grouped in the same workbook—a single file on the computer that in-
cludes multiple spreadsheets.) It is especially easy then to tell the com-
puter to put in the third spreadsheet’s cells the results of multiplying
the corresponding cells in the two other spreadsheets.
Summary At this point, you have completed recording all personnel costs for the
chosen period on three spreadsheets:
 Resource Use shows the time each person spent with each
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Table 10. Computing hourly rates from annual salaries
1. Multiply the number of workdays per week (e.g., 5) by 52 (the
number of weeks in a year) to obtain the total workdays per
year.
Example: 5 days x 52 weeks = 260 workdays per year
2. From the total workdays per year, subtract the number of days
allowed for leave, vacation, and other nonworking activity
(e.g., 25).
Example: 260 workdays per year – 25 days leave/vacation
= 235 workdays per year
3. Multiply the workdays per year by the work hours per day to
obtain the total hours worked per year.
Example: 235 workdays x 8 work hours per day = 1,880 work
hours per year
4. Add the annual fringe benefits to the annual salary.
Example: $40,000 annual salary + $4000 (10%) fringe
benefits = $44,000
5. Divide the total of salary and fringe benefits by the work
hours per year to obtain the hourly rate.
Example: $44,000 1,880 = $23.40 per hour
patient performing each procedure, the time spent in other di-
rect activities, and time spent in indirect activities.
 Cost per Unit shows the hourly rate for each person and any vari-
ability in rate for specific procedures or specific patients.
 Resource Cost shows the personnel time multiplied by the ap-
propriate hourly rate for each procedure for each patient as well
as for other direct and indirect activities.
All three spreadsheets should be included as tables or appendices in re-
ports of cost-related analyses. Reporting only Resource Cost data will
make findings progressively less useful as years go by and monetary
units change due to inflation and other economic phenomena. Cost
per Unit Resource data describe many of the assumptions used in the
cost assessment and facilitate replication of the cost assessment. The
Resource Use spreadsheet provides information particularly useful for
replicating the program and its specific procedures.
Calculate the Cost of Space
Personnel is not the only resource used to provide services to patients.
The cost of office space used when administering a treatment proce-
dure to a patient also needs to be included, along with the cost of utili-
ties, furnishings, and equipment.
Record Usage Time The cost of space used to deliver individual therapy or other proce-
dures to a patient can be measured in a manner similar to personnel
costs. Enter the time that the particular space was used for a particular
procedure and patient on the Resource Use spreadsheet in the row
provided and the appropriate cell for that procedure and patient.
If the total cost of specific indirect services is to be calculated, also enter
the time that a specific space was used in the appropriate row in the col-
umn for the designated indirect activity. Otherwise, the total space cost
minus the cost for space used for direct patient services will be assigned
to general indirect services.
Find the Total Cost
per Hour
Just as for personnel, the next step is to find the hourly rate for each de-
fined space and enter it in the Cost per Unit Resource spreadsheet.
Begin by determining the annual cost of the following:
 Lease or Rent. An accountant or administrator should know the
cost of leasing the total clinic space. However, this lease cost may
not reflect the value of the space used by the clinic if your pro-
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gram uses space given to you at low or no cost by a hospital, gov-
ernment agency, or private firm.
 In that case, the value of that space on the open market (the op-
portunity value of the space) is what you will need to use as your
space cost. The highest amount of money that would be paid for
that same space, in that same location or town, by a private enter-
prise probably is your best estimate of the opportunity value of
the space. You can find that value by average rates quoted for that
space, or very similar space in the same locale, by local real estate
agencies (Yates et al. 1979).
 Utilities and Maintenance. Add the annual utility and mainte-
nance costs to the total cost of your space.
 Office Furniture and Equipment. If the space is fully furnished
and equipped by the leaser, these expenses probably are already
included in the lease payment. If not, furniture and equipment
expenses need to be included in cost calculations.
 The cost of furniture, office equipment, and similar resources
should be spread out over their useful lifetime. Standard life-
times often can be found in Federal tax or accounting guidelines.
The cost of a desk, for example, might be $1,200, but its monthly
cost might be only $10 over its useful lifetime. Also, to figure the
value of the desk, discounting should be applied to the monthly
cost. Discounting is described later in the manual.
 Donated Resources. Significant amounts of donated space, fur-
niture, equipment, supplies, and other resources should be con-
sidered. The market value of these resources often can be
determined with a few calls to neighborhood stores or commer-
cial providers of similar space or services. The market value
should be used in cost assessments just as if it had been paid.
Costs associated with donated resources can be tagged for later
removal to contrast the “actual cost, with donated resources not
paid for” with the “expected cost, if every resource had to be paid
for.”
 Renovations. Renovation costs for an entire facility should be
spread out over the expected life of those renovations. For exam-
ple, if building renovations are expected to last for 10 years,
one-tenth of the total cost of the renovation should be added to
the annual cost of the space.
To determine the hourly cost of your facility, divide the total space cost
by the number of hours it can be used for all procedures, including in-
direct as well as direct services. This probably would be the number of
hours the clinic is open (table 11).
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The same procedure can be used to calculate the cost of space in resi-
dential programs. Procedures can be delivered 24 hours a day, 7 days a
week, in some residential programs. Other residential programs may
limit treatment activities to 6:00 a.m. through midnight. In either case,
the above procedure can be used to calculate the hourly cost of space in
residential programs.
Find the Hourly
Cost of a
Designated Space
It is incorrect to assign all areas of a facility the same cost. For example,
therapy for an individual patient in an office measuring 8 x 10 feet
would not cost the same, in terms of space, as therapy in an office mea-
suring 10 x 15 feet. Rather, the cost of different areas should be propor-
tional to their share of the total space. Thus, an 8 x 10 foot office (80
square feet) would account for 10 percent of the total area of an 800
square foot facility (including hallways and other areas that cannot be
assigned to a direct service). If the hourly cost for the entire facility were
$3.74, the office space in question would cost $0.37 per hour.
However, if there is a marked difference in the quality of different areas
within the same facility, simply assigning costs as percentages of space
is not adequate. Instead, determine the costs of those resources (e.g.,
furnishings, equipment, utilities) that differ and apportion the costs by
direct treatment spaces and areas used for indirect activities. For exam-
ple, specific renovations performed on a particular office—say, adding
walnut paneling or a skylight—should be charged to that office only.
Then compute the hourly cost as above.
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Table 11. Calculating the hourly cost of space
1. Find the total annual cost of the entire facility: lease payment
or equivalent, utilities, maintenance, and pro rated furniture,
equipment, and renovations.
Example: $18,000 (lease) + $2,000 (utilities/maintenance) +
$1,800 (furniture, equipment, and renovations) = $21,800
(total annual cost)
2. Determine the number of hours that the facility is open during
the year: hours per day, days per year.
Example: 16 (hours per day) x 7 (days per week) x 52 (weeks
per year) – 2 (holidays) = 5,822 hours per year
3. Divide the total annual cost by the hours open per year to
obtain cost per hour.
Example: $21,800 (total cost) 5,822 (hours) = $3.74 per hour
Alternatively, special equipment or furnishings could be listed sepa-
rately in rows added to the spreadsheet, and the time spent using them
would be placed in the appropriate column for procedure and patient.
The hourly cost for their use would be shown in the proper cell in the
Cost per Unit spreadsheet, and the cost would be computed for the Re-
source Cost spreadsheet.
Record Hourly
Rates
The final step is to calculate the space cost for each procedure and pa-
tient. Multiply the time that the procedure was performed by the pro-
vider for the patient in that space (entered in the Resource Use spread-
sheet) by the hourly cost of the space (entered in the Cost per Unit Re-
source spreadsheet). The spreadsheet column totals will yield the total
direct service cost of the space in the Resource Cost spreadsheet.
Other Direct Costs
Some costs are entered directly in the Resource Use spreadsheet and
can be transferred directly to the Resource Cost spreadsheet. Other
costs may have to be calculated. For example, you may decide to record
number of doses of methadone per patient for the month on the Re-
source Use spreadsheet. The cost per dose would then be entered on
the Cost per Unit Resource spreadsheet. The result of multiplying the
two entries would appear on the Resource Cost spreadsheet.
Fortunately, mileage and phone rates are readily available from billing
receipts and can be used to complete the Cost per Unit Resource
spreadsheet. Multiplication of these rates by the total amount of trans-
portation miles, phone use, and so on results in total costs, which are
entered on the Resource Cost spreadsheet.
Divide Indirect Service Costs Among Patients
Deciding how to distribute indirect costs provides an overview of the
cost assessment and shows how important it is to measure direct ser-
vice costs accurately.
One way to distribute indirect costs is to “charge” all patients the same
fraction of indirect service costs. This flat rate approach to assigning
costs is fair and accurate only if all patients use the same amount of di-
rect service resources. Because patients use varying amounts of re-
sources, gross distribution of indirect costs across patients rarely pres-
ents an accurate cost per patient.
A more accurate description of the value of resources actually used
(rather than available for use) is generated by finding the percentage of
direct service resources used by the patient and assigning the same
Find the Cost per Resource per Procedure per Patient
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percentage of indirect resource costs to the patient. Because patients’
use of direct service resources changes over time, the percentage
should be calculated for each basic reporting period.
Indirect resources can be distributed over patients according to criteria
other than the total direct costs of serving the patient. For example, the
number of hours the patient spent in treatment, or the number of visits,
could be used instead of total costs. It seems likely, however, that dur-
ing a visit some patients will use more treatment resources than will
other patients. These additional treatment services may well require
consumption of additional indirect resources such as more space or
administrator time.
For example, although it is possible that patients who see higher priced
therapists (such as psychiatrists) use the same amount of space, equip-
ment, and other materials as are used by patients who see less expen-
sive therapists (such as paraprofessional counselors), experience sug-
gests that higher priced therapists have nicer, larger offices, more
up-to-date equipment, and more of other resources. For similar rea-
sons, it seems likely that patients who spend the same amount of time
receiving treatment services may receive services that differ in indirect
as well as direct costs. Thus, the procedure used in this manual to dis-
tribute indirect costs over patients is based on the value of resources di-
rectly consumed in treatment, that is, direct service costs.
Determine Total
Direct Costs and
Patients’ Shares
Using the Resource Cost spreadsheet, find the total for each column
(except indirect activities) and enter it in the row for total direct service
resources. Then add up the column totals for each patient and enter
that in the TOTAL column for that patient. Next, add up all the patient
totals and enter that number in the TOTAL FOR ALL PATIENTS column.
That will be your total direct costs.
Next, calculate the proportion of direct services used by each patient
by dividing the TOTAL for the patient by the TOTAL FOR ALL PA-
TIENTS. If you are using computer spreadsheets, you can simply copy
the formula developed for one patient and use it for all other patients.
Be careful to type in the formula so that it always refers to the same total
cost for all patients.
Similarly, compute the proportion of direct resources used by each pa-
tient for each procedure. That is, take the total from one procedure
column for a given patient and divide it by the total cost for all patients.
Enter that proportion, then calculate the proportion for the next pro-
cedure for that patient, and so forth.
Enter the proportions in the appropriate row on the Resource Cost
spreadsheet. Every column with a total should have a percentage in the
row below it, except the columns for indirect costs.
Divide Indirect Service Costs Among Patients
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Determine Total
Indirect Costs
Next, find the total indirect costs of your program. Start by totaling the
columns under Indirect activities. All personnel costs should be ac-
counted for here or in direct costs, but other resources may require fur-
ther calculations. For example, all costs for space must be included.
Some space will have been listed under direct costs (and some may
have been designated for indirect activities).
 Total the rows for each designated space and add these totals
together.
 Subtract these allocated costs from the total cost of your space
and enter that number in the space row and the total indirect ac-
tivities column.
 To check your accuracy, retotal the space rows and add these
row totals together; this should give you the total cost of your
space.
In the same way, total each `other resources’ row where costs have
been allocated and subtract the total from the total cost of that re-
source. Enter this number in the total column for that resource. An ex-
ception would be resources that are used entirely for direct treatment,
such as methadone.
Enter the monthly costs of all other resources not otherwise accounted
for in the appropriate row in the TOTAL column under Indirect Activ-
ities. When all numbers are entered, retotal the columns for Indirect ac-
tivities and enter the numbers in the row for Total indirect service re-
sources. Then add these column totals together and enter the total in
the same row in the TOTAL FOR ALL PATIENTS column.
Assign Indirect
Costs
The next step is to multiply the proportion of direct costs used in each
column by the total of indirect costs as entered in the TOTAL FOR ALL
PATIENTS column. Enter that number in the Total Indirect Service Re-
sources row.
Combine Indirect
and Direct Costs
The final steps in cost assessment are to combine the indirect and di-
rect costs for each procedure and for each patient. This amounts to
adding up the indirect and direct costs for each procedure, then for
each patient, and finally for the program as a whole. Computer spread-
sheets make this easy, and it is especially easy to repeat each month as
new cost data come in.
Sample Resource Sheets
Tables 12 through 14 give examples of the three spreadsheets de-
scribed here. In order to show the calculations and indirect cost distri-
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butions, the figures unrealistically assume that only two patients are
sharing all resources, including group counseling, and that space and
other indirect costs are only large enough to accommodate two
patients.
Keeping Down the Cost of Measuring Costs
Although continual measurement of costs for all patients and proce-
dures usually is best from a measurement perspective, there are several
other ways to measure costs per resource per procedure per patient
that may be less expensive. You may want to consider these if your cost
assessment budget is small. Keep in mind, however, that the most
time-consuming and, in turn, most costly efforts are in the beginning.
Once you have a process in place with all the necessary pieces, it is fairly
easy to replicate, update, and reassess costs at different times.
One approach to reducing the cost of cost measurement while main-
taining its potential to contribute to cost-effectiveness and cost-benefit
analysis is to sample. If costs are measured for a representative few
months instead of a whole year, and if a representative group of pa-
tients is followed, the costs of measuring costs for the rest of the year
for the remainder of the patients can be saved.
It is important that the months used not be ones during which patient
load was particularly high or low or when average patient length of stay
was atypically long or short. A random sample of patients would be cru-
cial, too, for generalizing cost findings to other patients. To avoid se-
lecting time periods that are not representative, you may want to
choose several different time periods, such as one month out of each
quarter.
Another way to make cost assessment easier is to divide up the tasks. It
would be natural to divide up cost assessment into data collection and
data analysis tasks and let different people be responsible for the col-
lection and analysis. These methods of cost measurement reduction
deserve attention. You might also consider sharing cost measurement
efforts with similar programs in your area, pooling your cost data, and
sharing your solutions to cost measurement problems.
Finding Information on Cost Measurement
Cost measurement at the level of detail described in this manual is rela-
tively new to human services. Most cost-measurement methods have
been more global; they have been used for purposes of judging a pro-
gram’s overall cost rather than finding specific ways to improve
Finding Information on Cost Measurement
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cost-effectiveness and cost-benefit by adding, deleting, or modifying
treatment procedures.
Some additional sources of information, cost measurement methods,
and case studies are available in the professional literature. These in-
clude the following:
A Client-Oriented System of Mental Health Service Delivery and Pro-
gram Management: A Workbook and Guide by D.E. Carter and
F.L. Newman, 1976.
Integrated Clinical and Fiscal Management in Mental Health: A
Guidebook by F.L. Newman and J.E. Sorensen, 1985.
Improving Effectiveness and Reducing Costs in Mental Health by
B.T. Yates, 1980.
Cost-Effectiveness Analysis and Cost-Benefit Analysis: An Introduc-
tion by B.T. Yates, 1985.
Cost-Effectiveness Analysis, Cost-Benefit Analysis, and Beyond:
Evolving Models for the Scientist-Manager-Practitioner by B.T.
Yates, 1995.
Analyzing Costs, Procedures, Processes, and Outcomes in Human
Services by B.T. Yates, 1996.
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Collect Patient Data
Simply comparing outcomes to costs for an entire program does not
provide enough information to allow for systematic improvement of a
treatment program for several reasons:
 At any given time, patients will have been exposed to varying
amounts of treatment.
 Patients respond differently to different treatment procedures.
 Patients with different backgrounds and drug abuse histories
may respond differently to the same treatment procedure.
 Differences in backgrounds between therapists and patients may
influence the response to treatment.
What is needed is a record, for each patient separately, of the patient’s
characteristics, types and amounts of outcomes achieved, treatment
procedures used, and resources expended. These individual findings
can then be combined to show the effectiveness of the program as a
whole and of its individual parts.
To understand whether and how a treatment procedure is responsible
for outcomes observed, it is also useful to collect data on psychological,
social, and possibly biological processes that occur within individual
patients. Although difficult to observe directly, these biopsychosocial
processes translate what is done in treatment—the procedures en-
acted by counselors and others—into the end results of treatment—the
outcomes.
Before Treatment Begins
Patient
Characteristics
Most of the data on patient characteristics such as the following are col-
lected during the intake process:
 Date of birth
 Gender
 Ethnic background
65
 Employment status
 Marital status
 Drugs abused
 Physical health
 Severity of the abuse problem—the Addiction Severity Index is
commonly used to measure this.
 Contacts with the criminal justice system
 Date treatment begins
This information is kept in the patient’s file. In a large program with
many patients, especially if computerized, the data could be recorded
on a Patient spreadsheet similar to the spreadsheets developed to track
costs, with characteristics as rows and patients as columns.
Provider
Characteristics
To be able to determine whether patient outcomes are related to char-
acteristics of the program staff, record date of birth, gender, marital sta-
tus, ethnic background, experience, and training for all therapists and
staff members who interact with patients. These can be coded as pro-
vider data and entered on the Patient spreadsheet, if used.
Prescribed
Treatment
Some measure of amount of treatment that the patient has received
should be developed. This could be time in treatment, percentage of
prescribed treatment completed, or some other measure, depending
on the type of program. A patient who has finished only half the pro-
gram cannot fairly be compared with patients who have completed all
their treatment.
In order to determine the proportion of treatment received, you will
need to know the amount of treatment prescribed. In most cases, this
can be recorded as hours per procedure. In all cases, amount of treat-
ment recommended should be expressed numerically, if possible.
Process Measures Several well-tested instruments for assessing specific problem areas are
available:
 General brain functioning
 Trail Making Test
 Neurological impairment
 Porteus Maze
 Depression
 Beck Depression Inventory (BDI) (Beck and Steer 1988)
Collect Patient Data
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 Anxiety
 Taylor Manifest Anxiety Scale
 State-Trait Anger Expression Inventory (STAXI)
 Health functioning
 SF–36
 Motivation
 Addiction Severity Index (ASI) (McLellan et al. 1985a, b)
 CMRS (Circumstances, Motivation, Readiness and Suitabil-
ity) (DeLeon and Jainchill 1986)
One instrument, the Symptom Check List, 90-item version, revised
(SCL–90–R) (Derogatis 1979), is designed for diagnosis of multiple
mental health problems and collection of related demographic data. It
can be used to measure the following processes that should change
during substance abuse treatment:
 Somatization
 Obsessive-compulsive
 Interpersonal sensitivity
 Depression
 Anxiety
 Hostility
 Phobic anxiety
 Paranoid ideation
 Psychoticism
 Global Severity Index
 Positive Symptom Distress Index
 Positive Symptom Total
Some instruments have been developed that, although more
time-consuming than those listed above, provide measures of almost
any process that could be posited as active in substance abusers:
 Minnesota Multiphasic Personality Inventory, version 2 (MMPI–
2)
 Millon Clinical Multiaxial Inventory–II (MCMI–II)
 Structured Clinical Interview for the Diagnostic and Statistical
Before Treatment Begins
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Manual of the American Psychiatric Association, version IV
(SCID)
In addition, some comprehensive process assessment instruments
have been developed specifically for substance abuse treatment. One
such instrument is the Individual Assessment Profile (IAP) (Flynn et al.,
1995).
Researchers have found that some personality factors measured by pro-
cess assessment instruments are indeed related to drug preferences
(Craig 1979; Flynn et al. 1995; Mirin et al. 1988); however, diagnoses
are not reliably related to treatment outcomes.
Standardized tests yield scores or ratings that can be entered in the pa-
tient’s file or on a Patient spreadsheet. These before-treatment scores
provide a baseline for comparison later in treatment.
During and After Treatment
Most clinical researchers and program evaluators begin outcome mea-
surement when a program has ended. Drug treatment is, however, dif-
ferent from many other programs: Patients typically begin dropping
out soon after treatment begins. Other patients are excluded early from
many drug treatments. If counseling sessions, medication, and other
procedures are interim outcomes, then outcome measures and
followup on treatment effects begin as soon as treatment begins.
Standardized
Effectiveness
Measures
There are many ways to record patient progress. Standardized mea-
sures give you the flexibility to look at each measure separately or to
combine all measures for an overall cost-effectiveness analysis.
To standardize different outcome measures, find a common unit in
which they can be measured or a common scale for all measures. This
may not be as impossible as you might first think. A common unit for
different measures, such as drug abstinence and employment, could be
days, where drug-free days and days of employment are treated as
equivalent, positive outcomes.
A common scale could be used for less observable measures, such as
emotional maturity and quality of relationships with others, where “1”
on the scale means “much less than desirable for recovery” and “10” on
the same scale means “as much as is desirable for recovery.”
Another way to standardize measures is to measure them at the begin-
ning and end of treatment (or at least earlier and later in treatment).
Calculate the percentage change in the measure, and the effectiveness
of the program on all measures will be in the same units. For example,
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if days employed per month increased from 5 to 10, a 100-percent im-
provement occurred. If drug-free days per month increased from 5 to
20, a 300-percent change occurred.
Followup How long does one have to follow a patient to determine whether the
cessation of substance abuse is permanent? This is a very difficult ques-
tion to answer conclusively. Relapses to drug use have been recorded 5
and even 10 years after the last use of the substance. One way to deter-
mine the length of followup is to specify an interval that is convenient,
affordable, or typical. The typical interval is between 1 and 2 years, al-
though longer periods are desirable.
Another way to answer the question “When will we know for sure that
the patient has or has not succeeded in kicking the habit?” is to chal-
lenge the validity of the question. A number of therapists and research-
ers believe that addiction is a lifelong process that may never end com-
pletely. Instead, the interval between uses of the addictive substance
may be increased markedly by treatment. The duration of the relapse
and the dose of the substance may be decreased by treatment. The ad-
diction, however, may continue forever.
If this is the approach to treatment outcome, followup becomes a po-
tentially perpetual process; however, budget limits and evaluator inter-
est typically limit duration of followup in these programs to a few years.
Should Dropouts Be Included?
It is tempting to exclude from evaluations of treatment outcomes data
for patients who have dropped out of treatment. Counselors may
rightly feel that behaviors exhibited by patients who quit treatment in
the first month or two do not represent the real effectiveness of treat-
ment. Indeed, these patients have not received the minimum necessary
“dose” of treatment and probably do not show how effective it can be.
Nevertheless, patients who dropped out did consume resources dur-
ing treatment. Because intake is an expensive procedure in most sub-
stance abuse programs, it would be inaccurate to distribute those in-
take costs across patients who stay in treatment. When costs are exam-
ined, that approach would penalize programs that have higher dropout
rates.
Also, if dropouts are excluded from analyses of program outcomes, and
if the costs of treating dropouts are excluded as well, treatments that
exclude all patients except those who succeeded will appear more suc-
cessful than treatments that persist in trying to help patients with more
serious problems. This creaming (as it is called by program evaluators)
can produce findings of apparent effectiveness, cost-effectiveness, and
Should Dropouts Be Included?
69
cost-benefit that cannot be generalized to most other programs. The
problems of ignoring dropouts become severe if the early dropout rate
is a significant percentage of the total number of patients who seek
treatment from the program.
Of several resolutions possible for the issue of what one does with out-
come and cost data for dropouts, the most satisfactory for most pro-
grams is to include the cost of treatment for dropouts and to think of
staying in treatment as a crucial interim outcome.
The perspective from which outcomes are being assessed also suggests
including dropouts in outcome measurement. The dominant perspec-
tive in most substance abuse treatment is that of the community or soci-
ety. This is due to the widespread effects that substance abuse can have
on the public as well as the public nature of much funding for sub-
stance abuse treatment.
From this perspective, the question that outcome and cost measures
should answer is not, “How effective and inexpensive can treatment
be?” It also is not, “How effective and inexpensive was treatment for
those who finished the basic course of treatment procedures?” From
the perspective of the community and of society at large, the question
of outcome is, “How many of those who needed to cease their addictive
behavior actually did so, did so permanently, and at what actual cost?”
Another way to look at this is to ask, “How much does it cost to operate
our program and what do we get from those costs?” From this perspec-
tive, serving dropouts, for even a short time, is part of what the program
does. Costs are associated with this service. Further, using the CPPOA
model allows for associating costs and resources as well as procedures
specific to dropouts so that ways to reduce these costs or change proce-
dures to reduce dropout rates can be adopted.
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Find Cost-Effectiveness
There are many ways to assemble numbers about your costs and out-
comes (effectiveness and benefits). Some may be more useful than oth-
ers, depending on your program and your funding situation. Each
method of assembling cost and outcome data, together with its possi-
ble determinants, serves a slightly different purpose. Graphs usually
show the best picture of the costs paid for treatment and the results of
treatment. Tables and ratios give a simpler picture but may bury or
eliminate important information that could change your decision
about which treatment procedures to use or which programs to fund.
Mathematical models, which are wonderfully complex, are beyond the
scope of this manual.
Measure Effectiveness
Traditionally, effectiveness is analyzed one measure at a time to pro-
vide a comprehensive picture of what a program is doing with its re-
sources. To analyze overall effectiveness, standardized outcome mea-
sures can be multiplied by a weighting to show their relative impor-
tance. These standardized, importance-weighted measures of effective-
ness then can be combined into an overall measure of effectiveness.
This method of integrating specific measures of effectiveness into one
overall measure was described by Yates and associates (1979) in a
cost-effectiveness analysis of residential treatments for predelinquent
youth.
Weight
Effectiveness
Measures
Even with the same units or same scale, the same improvement on two
measures may not be valued the same. For example, many counselors
would view a 50-percent improvement in drug-free days to be more im-
portant than a 50-percent improvement in gainfully employed days.
The importance of each measure can be rated by persons involved in
funding decisions. For instance, eight staff and two community repre-
sentatives could rate each measure of effectiveness for importance on a
10-point scale, with “1” meaning “much less important than the other
measures” and “10” meaning “much more important than the other
measures.” A 10-point scale has the advantage of not providing a mid-
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point that can be used to say “as important as other measures.” Having
an even number of rating points forces raters to decide whether a mea-
sure is less or more important than the other measures. Table 15 shows
a simple example with two measures of outcome and two raters.
Because some raters might use one part of the scale more than others,
the first step in standardizing the ratings is to standardize ratings be-
tween raters. This sounds more complicated than it is. Find the average
rating for a rater, and then divide each rater’s ratings by his or her aver-
age rating. The result will be numbers slightly greater or less than 1.00
(table 16). An importance number (weighting) greater than 1.00 indi-
cates that the measure is considered more important than the other
measures. An importance weighting less than 1.00 indicates that the
measure is considered less important than the other measures.
Do the same calculations for each rater. Now average these importance
ratings for all raters. The result is the average importance weighting—a
numeric consensus on how important each measure is (table 17).
You are now ready to calculate the composite measure of overall effec-
tiveness. Multiply the average importance rating for a measure by the
effectiveness value for that measure, and add up the products (table
18). The result is a single composite index of program effectiveness for
the patient. You can then average across patients to describe the effec-
tiveness of the program as a whole.
Table 18 shows that without importance weightings, Patients A and B
would show the same improvement. With importance weightings, Pa-
tient A’s improvement on the more important outcome measure be-
comes clear. Table 18 also shows that, after averaging across patients
and outcome measures, the original average percentage change in out-
come measures (60 percent) reappears. The effect of averaging across
outcome measures is to cancel out the effects of importance
weightings. So, why did we do all those weightings to begin with? These
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Table 16. Importance weighting index
Rater
Outcome
measure
Importance
rating (1–10)
Importance
weighting
A
Drug-free days 10 10  8 = 1.25
Employed
days
6 6  8 = 0.75
Average
(10 + 6)  2 =
8
(1.25 + .75)  2 =
1.00
B
Drug-free days 8 8  6 = 1.33
Employed
days
4 4  6 = 0.67
Average (8 + 4)  2 = 6
(1.33 + 0.67)  2 =
1.00
Table 17. Average importance weighting
Rater Outcome measure
Importance
weighting
A
Drug-free days 1.25
Employed days 0.75
B
Drug-free days 1.33
Employed days 0.67
Average for
all raters
Drug-free days
(1.25 + 1.33)  2
= 1.29
Employed days
(0.75 = 0.67)  2
= 0.71
Table 15. Importance
ratings on two outcome
measures
Rater
Outcome
measure
Importance
rating
(1–10)
A
Drug-free
days
10
Employed
days
6
B
Drug-free
days
8
Employed
days
4
importance-weighted outcome measures are important to retain when
examining cost-outcome relationships per patient. That way, the pro-
cesses, procedures, and resources that increase the more important
outcome of drug-free days will be given more weight.
These importance weights are, of course, subjective. They are no more
subjective, however, than most psychological measures. “Subjective”
does not mean that these measures are inherently bad or that they can-
not be used. Importance weights simply describe what most people do
when they read program evaluation reports with several measures of
effectiveness, according to psychological theory backed by laboratory
research (Anderson and Shanteau 1970). Most people do not attach
equal importance to each of the many effectiveness measures available
in most program evaluations. The ratings recommended here just
make explicit the psychology of the readers of an evaluation report. If
one measure of effectiveness is being ignored, that will be apparent in
the ratings.
Within specific interest groups, these importance weights may be quite
similar. If a policymaker wishes to use a particular set of importance
weights, that certainly can be done. Or, representatives of the various
interest groups each can be polled for their weightings of the impor-
tance of different measures. Better yet, perhaps the different degrees to
which each of these outcomes predicts long-term abstinence from sub-
stance abuse or long-lived contributions to society could be measured
by statistical analyses of large data sets and then applied as importance
weights here. Cost-effectiveness analyses, such as those reported by
Yates and associates (1979), have included these importance weights
obtained by surveying treatment staff for ratings of the relative impor-
tance of different outcome measures.
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Table 18. Composite index of program effectiveness
Patient Outcome measure
Percentage
change
Average
importance
weighting
Importance-weighte
d percent change
A
Drug-free days 110 % 1.29 141.9 %
Employed days 10 % 0.71 7.1 %
Average 60 % 1.00 74.5 %
B
Drug-free days 10 % 1.29 12.9 %
Employed days 110 % 0.71 78.1 %
Average 60 % 1.00 45.5 %
Average
for
program
Drug-free days 60 % 1.29 77.4 %
Employed days 60 % 0.71 42.6 %
Average across
outcome measures
60 % 1.00
60 %
[(77.4 + 42.6)  2]
Average across
patients
60 %
[(74.5 + 45.5)  2]
Newman Tables One way to measure outcomes so that they reflect the contribution of the
program is to compare outcome measures before versus after treatment,
or before versus after treatment begins. For example, the number of crimi-
nal acts could be compared for 1-year periods before and after treatment
begins. Another way is to construct a Newman table that displays the num-
ber of patients who began treatment at one level of functioning (or other
outcome measure) and ended treatment at another level.
A basic form of the Newman table is displayed in table 19. The numbers
in the table show the number of patients who began treatment at one
level of functioning (indicated by the labels in the rows) and ended
treatment at another level of functioning (indicated by the labels in the
columns). The numbers in parentheses show the percentages of all 90
patients that are in each cell of the table.
Table 19 shows that 11 patients who began treatment at the “Poor”
level ended treatment at the same level and 2 patients got worse. Func-
tioning improved for 71 (45 + 9 + 17) patients. Generally, Newman ta-
bles segment outcome measures into more levels (5 to 10) both before
and after treatment. These more detailed tables provide many more
cells, enabling a more specific analysis of the effects of treatment for pa-
tients who begin treatment at different levels of functioning (Carter
and Newman 1976; Davis and Yates 1982).
Before-after comparisons of outcome measures may exaggerate the im-
pact of treatment, since treatment often is started because patient be-
havior is becoming progressively more severe. Without treatment, pa-
tient behavior might have continued to worsen, of course, but it also
could have ebbed in severity because of processes unrelated to treat-
ment. Criminal behavior, for example, seems to decline as patients
grow older. Before-after comparisons of the same outcome measures
for individuals who did not receive treatment, but who are as similar as
possible to the patients, can help discern how much of the apparent im-
provement in patient behavior is due to other factors.
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Table 19. Sample Newman table
Pretreatment
functioning
Posttreatment functioning
Poor OK Great
Poor
11
(12%)
45
(50%)
9
(10%)
OK
2
(2%)
5
(6%)
17
(19%)
Great 0 0
1
(1%)
Calculate Procedure Dose
By examining the time and other resources used for each procedure, it
may be possible to assess the degree to which a procedure was imple-
mented. Some procedures, such as certain individual and group thera-
pies, may have no set criteria that indicate whether the procedure was
fully implemented. The extent to which these procedures are imple-
mented is indeterminate. The dose for open-ended procedures can be
calculated for the month by minutes of implementation or number of
sessions (of standard duration). More hours spent in individual ther-
apy indicates a larger dose of that therapy.
If a set duration or set number of sessions is prescribed as the desired,
complete implementation of the procedure, the dose of the procedure
actually received by the patient can be captured as a percentage. The
percentage of procedure implementation can be calculated for each
patient by dividing the total time (or other measure of procedure im-
plementation) by the amount of time the procedure was supposed to
be implemented.
Other procedures, such as drug education and more formally pre-
scribed therapies, may be characterized with checklists of specific
steps, points, presentations, demonstrations, or other specific opera-
tions to be performed by service providers. The degree to which an op-
erations-based procedure actually was implemented can be calculated
according to the percentage of points on the checklist that were ad-
dressed or the number or duration of presentations delivered versus
desired. This requires a carefully operationalized description of the
procedure.
Some procedures, such as methadone maintenance, can be described
in absolute terms according to the total dose received for the month.
Some providers may find it more useful to specify the extent to which
methadone maintenance was delivered according to the actual versus
ideal number of days that methadone was received.
Even if patients are prescribed different amounts of specific treatment
procedures, the percentage implementation of each procedure can be
calculated easily for each patient and then averaged across patients for
each procedure. Sample calculations for these procedures are de-
scribed in table 20.
There are other ways to calculate the average implementation of a pro-
cedure. The averaging shown in table 20 considered each procedure to
be equal. The percentages shown in the rightmost column in the last
four rows of the table could be weighted by the amount of time that pa-
tients were supposed to spend in the procedure.
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To do this, multiply the number of hours prescribed for a procedure by
the percentage implementation of the procedure and divide by the to-
tal number of hours that procedures were prescribed. Working with
the averages for Patients A and B, shown in the bottom four rows of ta-
ble 14, the weighted average for percentage implementation of the pro-
cedures would be:
( % ( % . ( % . ( %
.
100 10 60 7 5 95 4 5 100 2
10 7 5
x x x xh) h) h) h)
h h
  
  

4 5 2
86 56
.
. %
h h
The monetary cost of the procedures also could be used for weighting
the implementation percentages for the various procedures.
Link Costs to Outcomes
Graphs show the straight-line relationship between costs and out-
comes in a program. Although you can make graphs with paper and a
ruler, it is easier and more accurate to use graph paper. The easiest way
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Table 20. Sample calculations for dose of operations-based
procedures
Patient Procedure
Prescribed
hours
Actual hours
Percent procedure
implemented
A
Group counseling 10 9
90 %
(9  10 x 100)
Relapse prevention 10 6
60 %
(6  10 x 100)
Individual
counseling
4 4
100 %
(4  4 x 100)
Case management 2 2
100 %
(2  2 x 100)
B
Group counseling 10 11
110 %
(11  10 x 100)
Relapse prevention 5 3
60 %
(3  5 x 100)
Individual
counseling
5 4
90 %
(4  5 x 100)
Case management 2 2
100 %
(2  2 x 100)
Average
Group counseling
10
[(10 + 10) 
2]
10
[(9 + 11) 
2]
100 %
[(90% + 110%)  2]
Relapse prevention
7.5
[(10 + 5)  2]
4.5
[(6 + 3)  2]
60 %
[(60% + 60%)  2]
Individual
counseling
4.5
[(4 + 5)  2]
4
[(4 + 4)  2]
95%
[(199% + 90%)  2]
Case management
2
[(2 + 2)  2]
2
[(2 + 2)  2]
100 %
[(100% + 100%)  2]
to graph cost-outcome relationships is to use a spreadsheet program
(like Microsoft Excel© or Lotus 123©) on a computer. There are graph-
ing programs, too, but most spreadsheet programs now include graph
“wizards” or assistants that make graphs easily.
You could begin using graphs to explore cost-outcome relationships by
graphing data for individual patients for one time period. Outcomes
are on the vertical axis because that, traditionally, is the place for the
variable of primary interest. Costs are on the horizontal axis because
that, traditionally, is the axis for the variable that is thought to deter-
mine the variable of primary interest. Cost and outcome data can be as-
sembled in a table or spreadsheet with columns for costs and outcomes
and rows for each patient (table 21).
Cost-Outcome
Newman Tables
Cost information also can be combined with outcome data in a
Newman table. Generally, the total or average cost of moving patients
from one level of functioning to a another one (or to maintaining the
same level of functioning) is displayed as shown in table 22.
These cost-outcome indices do not reflect what could be high variabil-
ity among individuals in the value of resources that were devoted to
their treatment. Within each outcome cell, there may be considerable
variability in patients’ responses to treatment. Having only three levels
of functioning also is a problem. For instance, a patient might begin
treatment at the low end of the “OK” level of functioning, end at the
high end of the “OK” level of functioning, and be tallied in table 22 as
“no change.”
Including cost information in a Newman table may confuse some
funders or lead them to hasty and erroneous decisions. A funder might,
for example, express amazement that an average of $672 was spent on
the five patients who began and ended treatment at the same “OK”
level. Why, it might be asked, was all that money spent yet no change
was produced?
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Table 21. Treatment cost
and drug- free days per
patient
Patient
Cost of
treatment
for
February
Drug-free
days in
February
A $512 23
B $716 19
C $632 20
etc.
Table 22. Cost-outcome Newman table
Pretreatment
functioning
Posttreatment functioning
Poor OK Great
Poor
11
($798)
45
($643)
9
($890)
OK
2
($152)
5
($672)
17
($801)
Great 0 0
1
($139)
Several answers are possible. One alluded to earlier is that change did
occur, but the outcome measure was not sensitive enough to detect the
change. Another answer is that, without treatment, these patients’
functioning would have deteriorated. A control group might allow for a
more direct test of this explanation, although the typical course of pa-
tients’ addictive behavior may suggest that most will get worse without
treatment.
Yet another answer is that it may indeed be possible that treatment did
not work for these five patients. Although definite costs were involved,
the outcomes of treatment cannot be guaranteed. Many other factors
affect patient functioning. Should treatment be responsible for factors
that are beyond the reach of treatment to change?
A final, possibly more constructive answer to hard questions about
funds spent with no apparent clear result is, although most patients
seem to benefit from treatment, we need to find out what procedures
and processes combined to produce outcomes that were less than
what we wanted.
Cost-Outcome
Ratios: Patient
Level
Several types of ratios can be calculated for programs, all of which may
be interesting but which represent with varying degrees of accuracy the
cost-effectiveness or cost-benefit of the program.
At the patient level, cost-outcome ratios can be formed by dividing the
total cost of treating the patient by the one outcome measure, or by a
composite outcome measure. For example, if the cost of treatment for
Patient A for one month is $80 and the change in drug-free days is 110
percent, the simple cost per percentage change in drug-free days is $80
 110% = $0.73 per month.
If we had divided the cost of a month of treatment by the number of
drug-free days during the month (say, 23 verified drug-free days), we
would have another type of cost/outcome ratio ($80  23 = $3.48 per
drug-free day). This would probably underestimate the cost of a
drug-free day, unless it can be assumed that there could be no drug-free
days without treatment.
These ratios can be calculated for each patient for a specific period of
treatment, such as the first 3 months, or for the entire treatment. They
also can be averaged for patients, like any other statistic. However, the
ratios do not describe the cost-outcome relationship over a wide range
of costs. For example, finding a cost-outcome ratio of $0.73 per per-
centage change in drug-free days for Patient A might make some people
think that $0.73 x 100 = $73 per month would produce a 100-percent
change in drug-free days for Patient A. This is unlikely to be the case.
A patient-level benefit/cost ratio also could be calculated by dividing
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the total value of criminal behaviors and social services avoided by the
cost of treatment during an appropriate period. If the sum of benefits
for these cost savings was $160 for Patient A, and the cost of treatment
was $80, the benefit/cost ratio would be 2.0. The question of what an
appropriate period is requires discussion. Basically, the cost should be
for the period of treatment to which the cost-savings outcomes can be
attributed.
Cost-Outcome
Ratios: Program
Level
The average patient-level cost-effectiveness ratio is a measure of pro-
gram cost-effectiveness. Sometimes, however, a few patients may have
especially low or high cost-effectiveness ratios that may throw off the
average. In such cases, other statistics, such as the middle cost-effective-
ness ratio for all patients (the median) or the most common
cost-effectiveness ratio for patients (the mode) might represent the
cost-effectiveness of the program better than the average.
Another approach to measuring the cost-effectiveness of a program is
to divide the total cost of the program by an outcome measure, or a
composite outcome measure. For example, if the total cost of the after-
care substance abuse treatment program is $5,400 and the total
drug-free days generated for all patients during that period was 100,
the cost per drug-free days would be $54 per drug-free day.
Cost-effectiveness ratios could be calculated for the other outcome
measures as well by dividing the program cost by the effectiveness mea-
sure. That assumes, however, that the total cost of treatment was de-
voted to drug-free days. It would be far more accurate to calculate the
portion of program resources that were directed specifically toward
the generation of drug-free days. Cost-procedure-process-outcome
analysis does this. A composite cost-effectiveness ratio could, however,
be calculated by dividing the total program cost by the composite effec-
tiveness index.
As the past few paragraphs implied, calculation of cost-effectiveness ra-
tios is not always simple, and the results can be misleading. Table 23 de-
scribes these ratios, notes whether they are true cost-outcome ratios or
another type of ratio, and also notes their sensitivity to how cost and
outcome are defined and measured.
Many of these ratios also can be calculated for individual patients, and
then summed. Generally, a cost-outcome ratio is more accurate and
more representative of program functioning if it is calculated for indi-
vidual patients and then averaged. Mathematically, the results can be
different than will result from calculating the average cost for individ-
ual patients and dividing that by the average outcome for individual
patients.
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Table 23. Cost-outcome ratios
Cost measure Outcome measure Resulting ratio
A cost-outcome ratio?
Sensitivities
Program level of specificity
Cost of treating all patients
who began treatment during a
particular period (say, the
second year of operations)
Number of patients who
stayed drug free for a specific
period after treatment and
who began treatment during
the same period for which the
costs are measured
Average cost per successfully
treated patient.
(Criterion for success: staying
drug free for the specific
period)
Yes
Very sensitive to length of
drug-free period and
definition of after treatment
Cost of treating all patients
who began treatment during a
particular period (say, the
second year of program
operations)
Drug-free day.
Does not distinguish between
one patient being drug free
for a long period and many
patients being drug free for
short periods
Average cost per drug-free
day
Yes
Sensitive to definition of
drug-free day and when
outcome measurement begins
Cost of treating all patients
who began treatment during a
particular period (say, the
second year of program
operations)
Monetary benefits (cost
savings, income production)
of treatment
Total benefit/cost ratios Yes
Sensitive to assumptions
made when estimating
monetary value of different
outcomes (e.g., cost of a
theft)
Individual patient level of specificity
Cost of treatment for
individual patients
Number of drug-free days for
individual patients
Average cost per drug-free
day, calculated separately for
each patient, then averaged
across patients
Yes
Does not distinguish between
long and short periods of
abstinence
Does not indicate variability
of treatment cost-
effectiveness between
patients
Cost of treatment for
individual patients
Total monetary value of
treatment outcomes for
individual patients
Dollars spent per dollar
produced
Yes
Sensitive to assumptions
made when estimating
monetary value of different
outcomes
False cost-outcome ratios
Cost of treating all patients
who began treatment
Number of patients beginning
treatment
Average cost per patient of all
patients who began treatment
No
This is a useful measure of
cost but is not of outcome.
Cost of treating all patients
who completed treatment
Number of patients who
completed treatment
Average cost per successful
patient
No
Including only the cost for
patients who completed
treatment underestimates the
cost
Cost of operating the
treatment program for a short
period, say one month
Number of patients seen one
or more times by the program
during the same short period
Average cost per patient per
short period
No
This is a potentially useful
measure of cost, sometimes
called slot cost, but it
involves no outcome data.
Costs per Procedure or Process
The most complete and useful cost-outcome analysis includes informa-
tion about treatment procedures and about internal patient processes
that occur between costs and outcomes. These analyses necessarily are
performed at the level of individual patients. This level of detail enables
us to see clearly what treatment interventions affect which processes in
which patients. This information can help you decide how to deliver
the most effective treatment to the most people given your budget
constraints.
Costs per Procedure or Process
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Explore Cost Benefits
Most interested parties agree that they seek to help patients become
less destructive and more productive members of society. In our soci-
ety, an individual’s contribution often is measured in monetary
terms—which is why transforming measures of effectiveness into mea-
sures of monetary benefits is so important, and why cost-benefit analy-
sis can be so useful for decisionmakers.
According to research by Ball and Ross (1991) and Gerstein et al.
(1994), substance abuse treatment can be expected to both save money
and produce new income. In California, various drug treatments were
estimated to save between $245 million and $1,284 million after sub-
tracting the cost of treatment from cost savings and income generated
in a single year in the early 1990s (Gerstein et al. 1994, p. 82). Of
course, every treatment program differs in how much (and how
quickly) this return on investment occurs, which is one reason to mea-
sure the benefits as well as the costs of individual programs.
Typical Benefits of Substance Abuse Treatment
New Income Real income may be generated by substance abuse treatment due to in-
creased productivity and employment of patients. This does not always
occur, however. Researchers have found that employment prospects
may not be as positive for former substance abusers as might be hoped
(cf. Gerstein et al. 1994). This may be due to the stigma of being a for-
mer substance abuser as well as difficulties posed by criminal records.
Also, the behavior patterns sometimes acquired in drug abuse lifestyles
may need to change radically to meet expectations of potential employ-
ers (such as getting to work on time every day and following directives).
Cost Savings Another benefit of substance abuse treatment is cost savings to society
or taxpayers. These cost savings include—
 Funds that otherwise would have been spent in the illicit econ-
omy for drugs.
 Criminal justice services not required.
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 Social and health services no longer required.
These cost-savings benefits are real and can be quite substantial. Sub-
stance abuse researchers (Langenbucher et al. 1993) have found pro-
found reductions in a number of costly events after treatment, includ-
ing the following decreases:
 Patients involved in driving while intoxicated/driving under the
influence arrests decreased from 18 percent (pretreatment) to 3
percent (posttreatment).
 Patients involved in accidents decreased from 14 to 1 percent.
 Patients’ families who sought counseling decreased from 31 to 5
percent.
 Patients’ children who missed school decreased from 5 to 1
percent.
 Patients’ spouses who missed work decreased from 10 to 1
percent.
Although different jurisdictions and different methods of assessment
may provide different figures, the level of criminal activity patients ex-
hibit can be expected to decrease by roughly two-thirds (Gerstein et al.
1994). Not every program produces a two-thirds reduction, however,
so it is essential to measure how much criminal activity changes for
each patient.
The reduction in criminal activity following substance abuse treatment
may not produce a corresponding reduction in actual costs to society.
Although costs to citizens drop in direct proportion to reductions in
criminal acts perpetrated on those citizens, public expenses for crimi-
nal justice services may not decline in a similar manner. Typically, po-
lice, courts, and other components of the criminal justice system are on
limited and fixed budgets, while the need for criminal justice services
greatly surpasses the ability to deliver those services. For this reason,
the impact of substance abuse treatment on criminal behaviors may not
result in an actual reduction in criminal justice expenditures. Instead,
criminal justice resources saved because of a reduction in crimes com-
mitted by former substance abusers may be diverted to other criminal
justice services. The entire budget for criminal services probably will
still be spent.
Similar problems may occur when cost savings benefits are measured
for reduced health, mental health, and future drug treatment services.
Because resources in these services typically are very limited, the actual
reduction in expenditures may not be as much as might be expected
from the reduction in patient use of services.
Nevertheless, transforming effectiveness findings into estimated cost
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savings still may have considerable value for a program evaluation. In
particular, cost savings estimates can show the magnitude of criminal
justice and treatment resources that are now available to help other
drug abusers who previously could not be helped because of budget
restrictions.
Crime-
Related Cost
Savings
Other research provides evidence for numerous cost savings that result
from drug abuse treatment. For example, Rajkumar and French (1996)
found that although total costs of crime averaged $47,971 per patient
in the year prior to treatment, that figure dropped to an average of
$28,657 per patient in the year following treatment. That drop of
$19,314 was far more than the cost of treatment, making cost savings in
terms of crime alone worth the cost of treatment: $2,828 for metha-
done maintenance, $8,920 for residential treatment, and $2,908 for
outpatient treatment (Rajkumar and French 1996).
Employment-
Related Cost
Savings
French and associates (1990) found that drug treatment improved the
employment and earning potential of drug abusers. Although only 31
percent of drug abusers were employed at the start of treatment, al-
most 45 percent were employed after treatment. There was a similar
increase in the number of patients seeking work (from 9 to 13 percent).
And, employed patients earned more after treatment. French and col-
leagues (1990) found that average personal earnings for employed pa-
tients rose from $6,158 during the year before treatment to $7,120 dur-
ing the year after treatment.
The legality of employment and income also can be positively affected
by drug treatment. French and Zarkin (1992) found that increasing
time spent in methadone treatment by just 10 percent increases legal
earnings by 1.5 percent and decreases illegal earnings by 3.2 percent. A
10-percent increase in time spent in residential programs increases le-
gal earnings 2.4 percent and decreases illegal earnings 4.1 percent.
Health
Service-
Related Cost
Savings
French and colleagues (1996) estimated the cost savings if one case of
the following health problems could be avoided:
 $1,100 for avoiding a case of severe venereal disease
 $74,513 for avoiding a case of severe hypertension
 $96,005 for avoiding a case of severe tuberculosis
 $114,796 for avoiding a case of AIDS
Caveats on Benefit
Assumptions and
Calculations
Reductions in each of the above events are notable in their own right, as
well as in terms of monetary savings to the individual and society. For
your program, the average cost of each event can be requested from
Typical Benefits of Substance Abuse Treatment
85
those providing criminal justice, health, or social services locally. It
also may be possible to glean this cost information directly from re-
cords of expenditures of public funds. The cost savings benefit then
can be calculated for each patient as the reduction directly experienced
in these events.
Some important changes may be impossible to monetize. For example,
patients who interrupted their education decreased from 12 to 4 per-
cent. Although this is a substantial decrease, it is impossible to deter-
mine the monetary value of this reduction. Other changes may not oc-
cur during the time period used to collect outcome data. For example,
patients’ financial problems may continue to occur for years after treat-
ment because of the length of time necessary to compensate victims
and pay off accumulated debt.
Increased Expenditures From Outcomes
Substance abuse treatment can temporarily increase patients’ use of
social services, including welfare support, disability payments, and
health services. Patients may become well enough to seek help for
health problems and to seek financial support from licit as opposed to
illicit sources.
According to the CALDATA study (Gerstein et al. 1994), enrollment and
payments received from various social services (other than health ser-
vices) increased 17 to 50 percent during treatment. Being in treatment
also may increase eligibility to receive a variety of social support
services.
These increases in expenditures need to be included in treatment out-
come reports. They should not be excluded simply because they do
not seem like benefits. They are monetary outcomes and must be con-
sidered. They will likely be canceled out by the cost savings and income
generated after treatment.
A case in point: In the CALDATA study, the costs of health services de-
creased between 1-year periods prior and subsequent to treatment
from a mean $3,227 to a mean $2,469 per person. Also, in a study re-
ported by Holder and Hallan (1986), private health insurance costs
dropped from approximately $100 per month per patient in the 2 years
preceding treatment to less than $14 per month per patient in the fifth
year following treatment (which is when most health sequelae of sub-
stance abuse should have subsided).
Cost savings and other benefits may vary considerably depending on
the type of treatment. In the CALDATA study, residential treatment was
associated with a 58-percent reduction in costs to taxpayers, whereas
methadone discharge was associated with a 17-percent reduction in
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costs to taxpayers. Also, longer treatment generally corresponded to
greater cost savings, although not for methadone maintenance.
Transform Effectiveness Findings Into Benefits
Effectiveness findings often can be transformed into benefit findings by
multiplying effectiveness data by a cost value. For example, to estimate
cost savings after treatment, the change in the number of thefts before
versus after treatment can be multiplied by the average cost of drug- re-
lated thefts in terms of property loss, victim losses, and criminal justice
expenses. Statistical analysis of data collected in an experimental de-
sign is the best way to determine whether these cost savings are signifi-
cant and can be ascribed to treatment. Other research designs, includ-
ing correlational methods, provide guidance and useful estimates. The
transformation procedure for figuring benefits from effectiveness find-
ings remains relatively straightforward.
The exact cost value used to transform effectiveness findings into bene-
fit findings is ascertained by surveying local criminal justice and social
and health service agencies. Ideally, you would find the cost of each
criminal act, the cost of each health service used, and so on, for each pa-
tient individually. If you cannot get that information, you may be able
to use estimates of average costs per patient for these effectiveness vari-
ables.
For example, suppose you know that the number of theft convictions
for a patient dropped from three in the year preceding treatment to
one in the year following treatment. Suppose, too, that the estimated
cost of a theft totaled $1,200 after adding costs of arrest, holding, and
conviction to the cost to citizens of lost property and mental anguish.
The total savings that could be attributed to treatment would be the
cost of thefts during a period prior to treatment, minus the cost of
thefts during a similar period following treatment. For this patient, that
would be:
(3 x $1,200) – (1 x $1,200) = $3,600 – $1,200 = $2,400 in cost savings.
It would be more accurate to find the actual cost of each theft. It is con-
ceivable that the one theft following treatment was quite minor com-
pared to the thefts preceding treatment. On the other hand, that one
theft after treatment could have cost more than all the thefts before
treatment.
There also may be too much variation between jurisdictions (and over
years) to allow a set cost for social services, health services, criminal jus-
tice services, and other cost items to be established for all drug treat-
ment programs throughout the country for all time.
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When cost savings and benefits involve health services, welfare, and
other services for which cost data are available for individual patients,
the cost for each patient needs to be contrasted for different periods of
treatment. These services can vary greatly between patients; an esti-
mate of the average health care cost per patient could result in over- or
underestimation of cost-savings benefits.
Table 24 lists examples of the types of costs and potential cost savings
that can be included in the survey. It is not meant to be complete. Note
also that room for a range of estimates is provided, in recognition of the
variability in costs of these services between patients and over time for
the same patient. Costs of the specific criminal behaviors of individual
patients then can be contrasted for the periods—
 Before versus after treatment.
 Before versus during treatment.
 During versus after treatment.
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Table 24. Types of costs and potential cost savings
Effectiveness
measure
Effectiveness-benefit transformation Benefit measures
Possible cost
savings
Criminal acts not
performed
Thefts at $___ / misdemeanor
$___/ felony
Assaults at $____
Savings to potential victims due to
income loss avoided, property not
damaged or lost, and health and mental
health services not needed
Drugs not purchased Opiates at $___ to $___/day
Cocaine and crack at $___ to $___/day
Other at $___ to $___/day
Money not spent on drug purchases
Criminal justice
services not used
Arrests at $___/ arrest
Jail at $___/day
Prosecution at $__/ day
Expense of criminal justice services
avoided
Drug treatment no
longer needed
$__ per patient per day for the mixture
of treatments provided
Cost of drug treatment no longer needed
Welfare payments not
provided
$__ per patient per day in welfare
payments
Amount of welfare payments not
provided
Disability payments
not made
$__ per patient per day in disability
payments
Size of disability payments not made
Health services not
used
Sum health care cost use for 6–12
months before treatment and 6–12
months after treatment
Cost of health services not used
Possible
benefits
produced
Employment (licit) Income earned from licit sources
Entrepreneurship
(licit)
New income (profit) from enterprise
Income taxes paid on
licit income
Amount of Federal, State, and local
taxes paid on licit income
Increased
productivity in an
existing job
Increased profit for employer, company,
and sole proprietorship
These costs can be examined separately for each category of potential
cost savings or actual income produced and then summed across all
categories to find the total benefit.
Net Benefit Cost-benefit analysis answers the question of whether the outcomes of
a program are worth the costs by—
 Measuring outcomes in the same units—dollars, usually—as
costs.
 Seeing whether the value of outcomes exceeds the value of costs
(by subtracting total costs from total benefits, which is called the
net benefit).
To calculate the total benefit per patient for a program, simply add up
the benefit figures for each of the specific measures. Similarly, to calcu-
late the total cost per patient for a program, add up the cost figures for
each procedure. Then you can calculate the net benefit (total benefits
minus total costs) for the patient. Add these up for all patients to find
the net benefit for the treatment program.
To make cost-benefit analysis more specific, list the specific costs of
achieving the benefits on each measure. Instead of adding up benefits
for all measures for one patient, and then summing or averaging across
patients, add up or average for all patients the benefits attained by a
program for one measure.
Present-Value
Benefits
Immediate positive outcomes are more valuable than delayed positive
outcomes. Nonmonetary outcomes rarely are adjusted for the amount
they are delayed, but monetary benefits often are. If costs and benefits
are to be compared, monetary benefits delayed by more than a year
from the time that costs occur can be adjusted for their delayed value.
The adjustment divides benefits by the sum of 1 plus a discount rate (of-
ten 0.08, 0.10, or 0.14). The discount rate closely resembles the inter-
est rate that could be earned if the money spent on treatment were in-
vested in another activity (such as a money market fund). Benefits de-
layed by 2 years are adjusted by dividing them by the result of multiply-
ing the sum 1 + (discount rate) by itself once (squared). Benefits de-
layed by 3 years are adjusted by dividing them by the result of multiply-
ing the sum 1 + (discount rate) by itself and then by itself again, and so
on.
The result of applying net present value to delayed benefits can be strik-
ing. Consider, for example, a stream of cost-savings benefits of $10,000
that occur at the end of the year for each of 3 years and a discount rate of
0.10. It is tempting simply to sum the benefits for a total of $30,000.
The net present value of the first end-of-the-year return is, however,
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$10,000  (1 +.10) = $10,000  1.10 = $9.091 following the calcula-
tion guidelines given above.
The net present value of the second year’s cost-savings benefit is
$10,000  [(1 + .10) x (1 +.10)] = $10,000  [1.10 x 1.10] = $10,000
 1.21 = $8,264. The net present value of the third year’s cost-saving
benefit is $10,000  [(1 + .10) x (1 + .10) x (1 + .10)] = $10,000 
[1.10 x 1.10 x 1.10] = $10,000  1.331 = $7,513. The total of these
net-present-value benefits is far less than $30,000. It is only $24,868.
The resulting present-value benefits reflect the declining value of bene-
fits that take longer to occur. The difficulties of making this adjustment
are minor, although two to three discount rates (say, 0.08, 0.10, and
0.14) should be used. The resulting benefit adjustments provide a
quantitative advantage of alternative procedures (and alternative treat-
ment programs) that produce benefits more rapidly.
Time to Return on
Investment
Net benefit is the result of subtracting costs from benefits. Present valu-
ing benefits reduces the value of benefits. Using present-value benefits
gives an appropriate advantage to programs that achieve their benefits
sooner. Present valuing benefits still, however, gives an advantage (ap-
propriately) to programs that take longer but achieve better benefits
than programs that produce quick but small benefits.
Time to return on investment is the time at which investment equals
monetary outcomes. The time it takes benefits to begin to exceed costs
for substance abuse treatment is of concern to funders and other inter-
est groups. Each patient can be monitored for the time actually elapsed
before the monetary value of the outcomes achieved equals the mone-
tary value of the resources used. The average time to return on invest-
ment then can be computed for all patients.
One way to do this is to keep each patient’s figurative “bill” on a lined
piece of paper or on a spreadsheet, such as the one shown in table 25.
“Investment” is the cost of treatment services delivered. “Return on In-
vestment” is the monetary or monetized benefit resulting from treat-
ment services. “Cumulative Investment” is the running total of all treat-
ment and other service costs. “Cumulative Return on Investment” is the
continuous total of all benefits (monetary and monetized) resulting
from treatment. “Net Benefit” is the result of subtracting the Cumula-
tive Investment from the Cumulative Return on Investment. An advan-
tage of keeping these data on a computer spreadsheet is that the cumu-
lative total and the net benefit can be automatically updated by the
computer each time you enter new cost (investment) or benefit data.
Table 25 could be completed just from the perspective of the present
treatment program, or from the perspective of past as well as present
treatments, or for society as a whole. In the “Return on Investment”
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column, one could add the patient’s debt to society—restitution owed
victims or the cost of criminal justice services. The balance unpaid from
previous treatment programs also could be added here.
Total investment in treatment expenses can be compared to the total
monetary value of outcomes achieved for a cohort of patients (say, the
first 100 patients entering the clinic following the first year of startup
and operation).
Time to return on investment can be contrasted for different groups of
patients, such as those receiving different procedures or exhibiting dif-
ferent processes. The cost-benefit of different procedures also can be
compared by contrasting time to return on investment for patients
treated by the different procedures.
Just as calculations of time to return on investment should include
present-value benefits, more delayed costs also should be adjusted for
present value. The latter procedure quantifies the judgment that pro-
grams that delay some costs are preferred over programs that require
all expenditures up front.
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Table 25. Sample cumulative costs and benefits and net benefit
Time Investment Return on investment
Cumulative
investment
Cumulative
return on
investment
Net benefit
Date
Cost of
treatment
services
delivered
Benefit to society,
patient, or other
individual
Running total
of all
treatment
costs
Running total
of all benefits
of treatment
Cumulative return
minus cumulative
investment
1/3
start
$376
(screening)
$376 0 –$376
1/5 $145 (session) $21 (drug-free day) $521 $21 –$500
1/6 $21 (drug-free day) $521 $42 –$479
1/8 $95 (group) $21 (drug-free day) $616 $63 –$458
1/8 $145 (session) $761 $63 –$698
1/9
$124 (income for
employed day)
$761 $187 –$574
1/9 $21 (drug-free day) $761 $208 –$553
Potential Problems With Cost-Benefit Analysis
Erroneous
Assumptions of
Linearity
The strength of cost-benefit analysis also is its weakness or, more accu-
rately, its problem. Because ratios can be calculated very readily (since
costs and outcomes are in the same monetary units in most cost-benefit
analyses), funders may make all the erroneous assumptions noted ear-
lier that are encouraged by cost-outcome ratios .
Net benefit and time to return on investment forms of cost-benefit anal-
ysis encourage similar, and similarly erroneous, assumptions. For ex-
ample, funders may incorrectly assume that because the benefit for an
investment of $100,000 in a substance abuse treatment program is
$50,000, doubling the investment to $200,000 will double the benefit
to $100,000.
The common pattern of diminishing returns on investment would di-
minish this anticipated benefit to less than double. It also is possible
that increasing the initial investment so much would allow entirely dif-
ferent (and much more effective and beneficial) treatment procedures
to be used.
Some funders also may believe that increasing the investment in treat-
ment might yield a quicker return on investment, which might not oc-
cur given limitations on how rapidly current treatment technology can
modify the behaviors, life skills, and lifestyles associated with substance
abuse.
Overemphasis on
Monetary and
Monetized
Outcomes
The major problem with all forms of cost-benefit analysis is that mone-
tary outcomes are the only outcomes considered. Most service provid-
ers, many patients, and some other interested parties believe that the
most important outcomes of substance abuse treatment can hardly be
quantified, much less monetized (translated into monetary outcomes).
To note that some nonmonetary outcomes, such as reduced crime, can
be monetized does not eliminate, but only reduces, this problem. Many
providers are unwilling to consider placing a monetary value on the
outcomes of their services. These providers often resent attempts by
persons outside the treatment program to monetize their outcomes.
Critics also note that cost-benefit analysis has been used to justify a
number of decisions that proved to be not only erroneous but disas-
trously so. For example, cost-benefit analyses conducted by State men-
tal health hospitals in the 1980s apparently were used to justify sudden
deinstitutionalization without preparation of the patient or the com-
munity. This removal of many mental patients from hospitals and
placement into communities that were not prepared to provide neces-
sary services exacerbated homelessness and amounted to abandon-
ment of some patients.
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This unwise decision does not necessarily mean that cost-benefit analy-
sis is itself unwise. Problems arise when only one perspective is consid-
ered; it is important to adopt multiple perspectives in cost-outcome
analyses. For example, in the deinstitutionalization analysis, only the
perspective of the State mental hospital was considered.
Resources for Cost-Benefit Analysis
Several good books discuss the value of using cost-benefit analysis to
evaluate programs (Nas 1996; Thompson 1980). A classic cost-benefit
analysis performed in mental health (deinstitutionalization of schizo-
phrenic patients) is provided by Weisbrod (1983). The much-discussed
CALDATA study (Gerstein et al. 1994) also deserves your attention, as it
is directly related to substance abuse treatment.
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Compare Programs and
Program Components
The preceding chapters explained how and why to collect information
on costs, procedures, processes, and outcomes (effectiveness and
monetary benefits) of substance abuse treatment programs. This chap-
ter provides strategies for deciding on changes in program operations
that should improve program cost-effectiveness and cost-benefit. They
are rooted in a common sense (and quantitative) approach to manag-
ing treatment programs called operations research. These steps can be
accomplished with simple graphs or complex mathematical equations.
(See Yates 1980, 1996, for more complex examples and more mathe-
matical strategies.) As with most endeavors, the more effort and time
you devote to cost-effectiveness and cost-benefit, the greater the poten-
tial rewards.
Cost-Outcome Decisions
Sometimes cost-outcome analysis is simple. If the question is “Which of
these two programs should be funded?” a quick decision may be possi-
ble. If, for example, Program A has much better outcomes than Pro-
gram B, and Program A clearly costs much less than Program B, the de-
cision is clear-cut. Program A is more effective or more beneficial (or
both) and is less costly. Table 26 presents (a) the ways in which two
programs can differ or be similar to each other in outcomes and costs
and (b) the cost-outcome decisions that result.
The same simple decision rules can be applied to two different treat-
ment procedures or even two therapists. These rules are summarized
in table 26, which is called a Fishman table in honor of the researcher
who first applied this table to cost-outcome analysis.
However, the simple phrases “Program A costs less than Program B”
and “Program A has better outcomes than Program B” hide a dilemma:
How does one decide when one program costs less than another, or
when one program has better outcomes than another?
Once adjustments have been made for differences in the number of
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patients served in competing programs, statistical analyses can answer
the question of whether a difference in costs or outcomes is real and
not just due to chance variations in the cost or outcome numbers that
were generated by the competing programs. Most spreadsheets come
with add-in programs or macros that perform t tests and several other
statistical tests. You have to show which columns of numbers (e.g., out-
come data for Programs A and B) you want to compare to see if the ap-
parent difference is real.
Statistical tests do not, however, answer how big or how important a
difference is. Statistical tests tell whether an apparent difference is not
just due to chance. The size of a difference can be described with aver-
age costs and other numbers. The importance of a difference is a judg-
ment that can be made by surveying community and patient represen-
tatives.
The Fishman table also illustrates another problem with simple com-
parisons of outcomes and costs. Even if there are only two programs, a
Fishman table does not indicate which decision is correct if Program A
has better outcomes than Program B but also costs more than Program
B.
Cost-Benefit Ratios
Even if Program A’s benefits exceed its costs, the question of which
should be funded still is not answered. It is possible that Program B’s
benefits exceed its costs as well. Should both B and A be funded?
Maybe, but only if their net benefits are similar. You could compare the
net benefit of Programs A and B to see which is bigger, and then choose
the program that has the bigger net benefit.
Check that the bigger net benefit of, say, Program B is not just a result of
Program B serving more patients at the same level of effectiveness as
Program A. Serving more patients can result in a bigger benefit, and a
bigger cost and a bigger net benefit, without the program being any
better than a smaller program.
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Table 26. Cost-outcome decision: Program A or Program B?
Cost
Outcomes
A has better
outcomes than B
A and B have
similar outcomes
A has worse
outcomes than B
A has lower costs
than B
Choose A Choose A Uncertain
A and B have
similar costs
Choose A Choose either Choose B
A has higher costs
than B
Uncertain Choose B Choose B
Suppose Programs A and B both double the value of cost—they both
generate the same ratio of benefits-to-costs of 2 to 1. Suppose, too, that
Program A gets funded at $100,000 a year to serve 100 patients from its
district of 100,000 people while Program B gets funded at $500,000 a
year to serve 500 patients from district of 500,000 people. (Note that
Program A and Program B have the same rates of being funded at
$1,000 per patient. They also draw patients at the same rate of 1 per
1,000 persons residing in their districts.)
Reflecting the programs’ identical benefit/cost ratios, Program A pro-
duces benefits that are double its cost for a net benefit of $100,000. Pro-
gram B produces benefits that are double its cost for a net benefit of
$500,000. Which program is better? Neither. Program B just has a big-
ger funding base and thus appears better. Its performance is no better
or worse than Program A’s. That’s easy to see if the net benefit per pa-
tient is calculated. Dividing the net benefit for Program A results in the
same net benefit per patient as for Program B:
$100,000 net benefit  100 patients = $1,000 net benefit per patient.
$500,000 net benefit  500 patients = $1,000 net benefit per patient.
Cost-Effectiveness Ratios
Problems due to large differences in funding base or patient load are
less likely to distort cost-outcome analyses that use nonmonetary mea-
sures of outcome. When the effectiveness of a program is measured, it
usually is measured for each patient individually. Effectiveness mea-
sures usually retain their per patient units, as in average drug-free days
per patient. Once the cost of treating a patient is figured out, it is easy to
divide the cost of treating the patient by the effectiveness measure to ar-
rive at a ratio of cost to effectiveness. These cost-effectiveness ratios can
be calculated for each patient in a program and averaged to describe
the typical cost-effectiveness of treatment.
Cost-effectiveness ratios are most useful in decisionmaking when com-
pared to cost-effectiveness ratios for other programs. If Program A re-
quires an average $27.43 per drug-free day produced, whereas Pro-
gram B requires an average $30.71 per drug-free day produced, then
Program A appears to be preferable because it is more cost-effective
than Program B—at least on this one measure of effectiveness.
Cost per drug-free day is a cost-effectiveness ratio that has a number of
useful characteristics. A day free of drugs is something concrete that
most people understand. Many people can appreciate a day free of
drugs as a challenging endeavor and an important achievement. Be-
cause of this, and because of the concrete value of money, the cost of
producing this day free of drugs also becomes more tangible.
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Cost per drug-free day suggests a standard metric that will be better
(lower cost per drug-free day) if either (a) less money is spent per pa-
tient, (b) more patients are free of drugs for a day, or (c) an individual
patient is free of drugs for more days. The problem with this
cost-effectiveness ratio is that you do not know whether condition (a),
(b), or (c) has occurred. In truth, probably each of these three condi-
tions occurred for different patients within the program.
Cost-Effectiveness Ratios Versus Cost-Benefit Ratios
You might ask yourself “How could Program A be more cost-effective
than Program B, when they were equal in terms of cost-benefit? Be-
cause benefit measures usually are derived from effectiveness mea-
sures by multiplying the effectiveness data by a monetary amount,
shouldn’t cost-effectiveness and cost-benefit be the same? In fact, why
do we need both? Why not just use the cost-benefit findings?”
Program A could be more cost-effective than Program B according to
one measure of effectiveness (patient drug-free days) because Program
A did a better job of changing patient behaviors related to that measure
of effectiveness. Or, maybe Program A used less costly procedures to
change the patient behavior. Program A might also be less cost-effective
than Program B on another measure of effectiveness (e.g., employment
of patients). The superiority of Program A in terms of the monetary
value of more drug-free days might be canceled out by the superiority
of Program B in terms of the monetary value of more employment for
patients. So, the overall cost-benefit of Programs A and B could be the
same even though they differed on specific measures of effectiveness.
This discussion points out an advantage of cost-benefit analysis,
whether done with ratios or net benefit calculations: Cost-benefit anal-
ysis gives a single answer (as long as one measure of cost and one mea-
sure of benefit are used). That makes decisions easier.
Cost-effectiveness analysis, whether done with ratios or other meth-
ods, shows how programs differ on specific measures of outcome. This
is better if you want to focus on one or two measures, or if you do not
agree with the way that placing a money value on an effectiveness mea-
sure biases the overall evaluation toward one measure or another.
When Cost-Effectiveness and Cost-Benefit Converge
Cost-effectiveness and cost-benefit analyses can both generate overall
measures that describe how well a program uses its resources to
achieve its goals. Calculating the cost-effectiveness index seems like a
lot of work, but, if you’ll recall the calculations needed to turn effective-
ness measures into monetary benefit measures, there was a lot of work
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in the cost-benefit analysis, too. The benefit calculations weighted for
importance each effectiveness measure in terms of money saved or
money produced. The calculations involved in generating the overall
effectiveness index substituted the importance weightings for the dif-
ferent monetary rates used in the benefits calculations.
You may prefer to use the importance weightings inherent in the differ-
ent monetary values assigned to a “drug-free day” or “employed days.”
These values will change over time as the value of money changes
through inflation, deflation, or currency adjustments. Also, as the mar-
ket changes, the value of a drug-free day and the amount one is paid for
a day of employment will change. Actual measures of program effec-
tiveness, such as drug-free days and days employed, seem more con-
stant. Their importance also may change over time, however, as a result
of changes in community norms.
The best advice probably is to conduct a cost-effectiveness analysis and
a cost-benefit analysis for each measure and each patient as well as for
all measures and all patients. That way, you’ll have answers to a host of
questions. You’ll also have more opportunities to find solutions to the
problems of how to get even better outcomes out of your programs.
When Net Benefit and Ratios Fail
Net benefit and ratios of benefit over cost and of cost over effectiveness
are informative because they reduce information on two sets of vari-
ables—costs and outcomes—to a single cost-outcome number. That
advantage can be a disadvantage, too: When information is reduced,
the cost-outcome number is more readily understood, but its context
and limitations are more readily ignored.
Consider the situation in which Program A has better outcomes than
Program B but also costs more than Program B. In this context, a deci-
sion to prefer the program with the higher net benefit per patient, or
the higher ratios of benefit divided by cost or cost divided by effective-
ness, could be incorrect for several reasons.
It is possible that the higher cost of Program A is too high. The net bene-
fit and the ratios provide no information on budget limits. Worse yet,
they do not tell you how much the program costs. That information was
discarded when costs were either subtracted from benefits, or divided
into benefits, or divided by effectiveness.
It is also possible that the poorer outcomes of Program B are too poor
to meet minimum criteria. Funding policy, community standards, or
law may dictate a certain minimum level of effectiveness or benefit, be-
low which a program should be closed. Information about minimal ef-
fectiveness or benefits is not included in the net benefit or ratio calcula-
When Net Benefit and Ratios Fail
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tions. And, as was the case with cost, information about the actual bene-
fits and effectiveness of Program B has been discarded, replaced again
by a difference or a ratio.
Cost-outcome ratios and net benefit also can obscure effects that level
of funding (and size of patient load) can have on the relationship be-
tween costs and outcomes. These relationships are easier to see if infor-
mation about costs and outcomes is preserved. One way to do this is
with tables contrasting costs for different outcomes. Another way is
with graphs.
Cost-Outcome Graphs
A decision about Programs A and B is possible, and collecting data on
costs and outcomes is an important step toward making the decision.
You need more information about acceptable costs and outcomes. In
particular, you need to know “where the line is”—literally, as you’ll see
in a moment—on both costs and outcomes. Making cost-outcome deci-
sions usually requires knowing the budget limit on costs. Some
cost-outcome decisions also require knowing what basic outcomes
must be achieved, at a minimum, by a program if it is to be funded.
These decisions may not require all the mathematical machinations de-
scribed in the preceding pages. Instead of calculating information on
costs and outcomes, graph them. Graphing outcomes on the vertical
axis and costs on the horizontal axis preserves information on both
costs and outcomes while also helping you see how the two may be
related.
In the following graphs, the values on the outcome measure would be
exactly what is observed by researchers. Change, if it is to be repre-
sented on the graph, can be shown as two dots labeled “pre” and “post”
for the same program, connected by a line to show their association. By
doing this, differences between different programs in “pre” values are
made explicit. Graphing the difference score could hide serious pre-
treatment differences in severity of substance abuse between
programs.
Add Limits Knowing the maximum tolerable cost (the budget limit) and the mini-
mum tolerable outcome (minimal outcome criteria) can help in
deci-sionmaking when the Fishman table fails to identify clearly which
program (or procedure or therapist) should be chosen. Graphs of out-
comes against costs help illustrate this point. Consider, for example,
the following cost-outcome situations.
In graph 1, Program A clearly is the better of the two: It has a better out-
come, and it costs less. The letter “A” is higher than “B” on the vertical
axis, showing how good the outcomes were. The letter “A” also is to the
Compare Programs and Program Components
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left of “B” on the horizontal axis, showing how costly the programs
were.
Likewise, in graph 2, Program A clearly is the better of the two: It has
better outcomes, and it costs the same as Program B.
Graph 3 poses a problem: A has better outcomes than B, but A also
costs more than B. Is A worth it? Should A be chosen and funded rather
than B? Only information about budget limits and outcome criteria will
answer the question. The answer even may be that neither Program A
nor Program B should be funded. Both might exceed budget limits, as
shown in graph 4.
Both Programs A and B might not achieve minimum levels of outcome,
as shown in graph 5, which also would recommend choosing neither
program. A more likely scenario is that Program A exceeds the mini-
mum acceptable outcomes, but at unacceptable cost, whereas Program
B keeps costs below the budget limit but does not achieve minimum ac-
ceptable outcomes. This situation is depicted in graph 6.
Cost-Outcome Graphs
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Graph 1. A is less costly and more
effective or beneficial than B
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Graph 2. For the same cost, A is
more effective or beneficial than B
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Graph 3. A is more effective or
beneficial, but also more costly
than B
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Graph 4. Budget limits in a
cost-outcome graph
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Note that Program A could have benefits that exceed costs, as could
Program B, but neither might meet the budget and outcome criteria. It
is not necessary to increase cost maxima or lower outcome minima.
What is needed, and what is likely possible, is a new program that has
adequate outcomes at tolerable costs. This is Program C, shown in
graph 7. Program C has a cost-outcome relationship that is positioned
below the maximum cost and above the minimum outcome.
More Than Two
Programs
Sometimes cost-outcome analysis is not simple. If a decisionmaker is
offered the sort of Program A versus Program B choice described ear-
lier, it is possible that someone has limited the choice so A is always
chosen. Usually, alternative programs are possible, if not currently in
operation. Often, there are more than two procedures or therapists. As
the number of programs, procedures, and therapists increases, the
likelihood that one program, procedure, or therapist will be the most
effective or beneficial, and the least costly of them all, decreases. The
decision becomes one of tradeoffs: At what point is better drug treat-
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Graph 5. minimum outcome
criteria in a cost-outcome graph
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Graph 6. Both A and B are
infeasible
O
u
tc
o
m
e
Cost
B
u
d
g
et
Minimum outcome
Minimum outcome
A
A
B
Graph 7. Only C is feasible
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ment not worth the additional cost? Graphs of cost-outcome relation-
ships are helpful in these situations.
Assumptions Encouraged by Cost-Outcome Ratios
and Revealed by Cost-Outcome Graphs
Ratios of cost to outcome provide a succinct index of program perfor-
mance that obviously includes information on outcomes and cost. By
dividing cost by effectiveness (or benefit by cost), though, potentially
valuable information is lost on the actual amount of resources con-
sumed and the amount of outcome achieved. Suppose, for example,
that a program generates an average 500 drug-free days per patient for
$5,000 per patient. The resulting ratio is $10 per drug-free day per pa-
tient. This ratio encourages an assumption that if more money could be
spent, more drug-free days would be produced.
This is not necessarily the case. It is more likely that investing more
money in treatment of each patient (say, doubling expenditures to
$10,000 per patient) would result in an increase in drug-free days, but
less than a doubling to 1,000 drug-free days.
It is possible, too, that doubling the funding of a program might allow it
to see double the number of patients. Suppose that the cost-outcome
ratio shows the cost per successfully treated patient. It is possible that
the same level of effective treatment would be provided, doubling the
number of successfully treated patients. One factor that works against
this is the limited flexibility of many human service systems, including
drug treatment systems. There simply might not be enough space and
counselors to see double the number of patients. Of course, additional
space could be rented and more counselors could be hired. Adminis-
trative costs would have to increase as well, in light of the increased re-
sources being devoted to treatment.
If there is enough extra space in the program facility, and if program ad-
ministrators have extra time, then double the number of patients can
be seen at even less than double the cost. It is more likely, however, that
limitations in the flexibility of program resources will increase the cost
of adding each additional patient (sometimes called the marginal cost).
This means that the return (in terms of number of successfully treated
patients) on investment in treatment diminishes as more patients are
added—the classic diminishing returns on investment.
Cost-outcome ratios also encourage the belief that a decrease in pro-
gram funding would decrease the number of successfully treated pa-
tients by the amount indicated by the ratio. If a program’s funding is de-
creased by 20 percent, for example, from $100,000 to $80,000 per
quarter, one should not assume that outcome also will decline by 20
Assumptions Encouraged by Cost-Outcome Ratios and
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percent. Some programs experiencing a 20-percent budget cut might
well survive and produce outcomes that decline only 5 to 15 percent.
The programs might find more effective procedures (such as more
group therapy and less individual therapy). Other programs might
have to close their doors if their budgets are reduced by 20 percent, cre-
ating a rather sharp decline in the number of successfully treated
patients.
In sum, ratios encourage funders of treatment to assume that there is a
straight-line or linear relationship between costs and outcomes. The
ratio is, essentially, the slope on a graph of costs and outcomes.
The preceding examples argue that it is rare to find a straight-line rela-
tionship between costs and outcomes that lasts for a significant range
of costs or outcomes. This observation recommends that a better un-
derstanding of possible cost-outcome relationships could be gained by
graphing costs against outcomes for a variety of programs (or program
funding levels).
If you want to go beyond graphs, the next major step in understanding
and improving cost-effectiveness and cost-benefit is delving into the
more mathematical techniques of linear programming and other forms
of quantitative operations research. As detailed in a book by Yates
(1980), operations research involves the construction and solution of
equations that express mathematically the relationships among costs,
procedures, processes, and outcomes. Budget constraints and out-
come goals are included in the mathematical expressions.
The quantitative model of the treatment system that is constructed with
these equations can be solved using linear programming either to max-
imize outcomes that can be achieved within budget (cost) constraints,
or minimize the costs of achieving set levels of outcome. Operations re-
search provides a variety of models and solution procedures that are
potentially useful for many problems facing substance abuse services.
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Improving Program
Cost-Effectiveness and
Cost-Benefit
The many actions and discussions involved in collecting information
on costs, procedures, processes, and outcomes of a treatment program
usually suggest several ways to improve the cost-effectiveness and
cost-benefit of the program. Common strategies are provided below.
Cost-Procedure Relationships
 Use less expensive resources that enable the same procedures
to be used in treatment, with the same effects on processes and
thus the same outcomes (such as providing the same individual
therapy using master’s-level counselors rather than doc-
toral-level psychologists).
 Use different treatment procedures—procedures that are less
expensive than current treatment procedures but that produce
about the same outcomes (such as nonresidential rather than
residential treatment).
Procedure-Outcome Relationships
 Use treatment procedures that yield better or quicker out-
comes, or both, but cost about the same as current treatment
procedures.
 Reduce the “dose” of treatment procedures to (but not beyond)
the point that the same outcomes are achieved with substantially
less intensive treatment procedures.
Cost-Procedure-Outcome Relationships
 Use treatment procedures that, although more expensive than
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current procedures, are so much more beneficial that they jus-
tify the additional costs.
Consider Different Perspectives
Additional perspectives may need to be considered in your
cost-effectiveness and cost-benefit analyses. For example, if you are
considering reducing a 12-month residential program to one of 6
months of residence followed by 6 months of gradually less structured
life in the community, have you considered the cost of this change for
other social services in your community? They may have to provide ad-
ditional services for patients who no longer are under your roof contin-
ually. Can they afford to do so and maintain their current level of effec-
tiveness or benefit?
Often neglected, too, is the patient’s perspective on costs and out-
comes. Programs often don’t consider the money and time nonresi-
dential patients spend getting to and from the treatment program.
Childcare issues and time taken off from work to attend sessions and to
follow up on referrals also may not be considered. It might be helpful
to ask patients what problems might arise as a result of changes in pro-
gram procedures.
Experiment With Change
Cost-effectiveness and cost-benefit analyses usually generate a variety
of suggestions for program changes that might, or might not, work.
Rather than trying to change program operations overnight, it is usually
wiser to try out the changes on a small-scale pilot basis. Changes in re-
sources and procedures that appear to work can be implemented
broadly. Changes that do not produce the expected better outcomes or
lower costs (or both) can be revised.
You might create a schedule for implementation of each type of change
on a trial basis. The schedule should also indicate a final date for a deci-
sion about whether the change should be continued, expanded, or
stopped.
Developing a quantitative feedback loop is key to CPPOA. That is, after
data-based changes are made to improve cost-effectiveness and
cost-benefit, more data should be collected to monitor the results of
those changes. A good system for collecting, managing, and feeding
back information on costs, procedures, processes, and outcomes inte-
grates measurement and analysis of cost, effectiveness, and
cost-effectiveness into routine program administration.
Improving Program Cost-Effectiveness and Cost-Benefit
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Develop Regular Reports
Experimenting with different ways of improving outcomes or reducing
costs (or both) requires that information on the possible results of
changes be available quickly. Regular (perhaps monthly) reports are
needed on the costs and implementation of different program proce-
dures and on the results of those procedures in changing patient pro-
cesses and producing outcomes.
Minimize the Cost You don’t need special or expensive software to make these reports.
The spreadsheet software used to collect and analyze cost and other
data can be used to automate reports. After all, the reports are compila-
tions of the data you have already collected. Most spreadsheet pro-
grams allow one spreadsheet to summarize data from other
spread-sheets, which allows you to construct spreadsheets—
 For counselors, summarizing cost, procedure, process, and out-
come data for their patients.
 For supervisors of counselors, summarizing cost, procedure,
process, and outcome data for (the patients of) the counselors
they supervise.
 For program managers, summarizing data for (patients of coun-
selors of) different supervisors.
After you have developed these summary spreadsheets, you can use
them again and again to generate the same type of reports. For a new
month, just change the cost, procedure, process, and outcome data in
the base spreadsheets. These changes will ripple through the spread-
sheets that consolidate data for counselors, supervisors, and managers.
To make it easier to show findings, you can add graphs to the spread-
sheets for each level of reporting. Simple bar graphs can show which
patients, counselors, or supervisors are experiencing better or worse
outcomes, procedure implementation, process modification, and
costs. Line graphs of the same data for successive months show change
trends over time. Once you create these graphs and save them along
with the spreadsheets, adding a new month of data for individual pa-
tients will automatically update all the graphs.
Tailor Reports to
Their Audience
Regular reports on costs, procedures, processes, and outcomes can be
useful to counselors, counseling supervisors, program administrators,
and patient representatives and advocates. A successful reporting for-
mat presents information tailored to the reader. This involves integrat-
ing information at three or more levels of specificity and presenting dif-
ferent reports to the persons who operate at each level.
Develop Regular Reports
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Program managers, for example, need summary information on the
costs and outcomes of the program as a whole. Supervisors of direct
service staff need outcome and cost information for patients of those
staff who report directly to them. Counselor supervisors also need in-
formation on what procedures each counselor administered to each
patient and what results these procedures had on patient processes.
Counselors need information on costs, procedures, processes, and
outcomes specific to their patients.
If counselors want to compare their outcomes, costs, procedures, or
processes to those of other counselors, they can ask their supervisor for
that information. The reporting system can provide supervisors with
average counselor statistics to make the comparison easier. (It might be
even more useful to provide supervisors with average counselor statis-
tics specific to each counselor. These comparison data would first re-
move the costs, procedures, processes, and outcomes for the coun-
selor who is being compared.)
Similarly, if supervisors want to compare their performance, they can
ask the program manager for comparison statistics. All program per-
sonnel who wish to compare their work to that of others can consult
persons operating at the next higher level of administration. Persons
at higher levels of administration can consult the staff who report to
them to get more specific cost, procedure, process, and outcome
information.
Improving Program Cost-Effectiveness and Cost-Benefit
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The CPPOA Model—An
Illustration
The following example illustrates how cost data can be collected and
analyzed for specific resource-procedure combinations for individual
patients. These data were obtained from an aftercare program that was
required of patients as part of their probation.
Program Context
The aftercare program usually included 3 months of participation in a
therapeutic community. The aftercare component was administered in
an office of the therapeutic community facility. A single counselor ran
the aftercare component with minimal support from a secretary and su-
pervision from the director of the program. The caseload usually was
30, all of whom were in a work release therapeutic community. Patients
attended one group counseling session and one relapse prevention
group per week. Patients also participated in one individual counseling
session per month. The counselor provided case management services
such as referrals, employment monitoring, and coordination with pro-
bation and parole officers.
Cost data were collected directly from staff—their best estimates of
which relationships existed among all the different resources, proce-
dures, processes, and outcomes.
After defining the essential resource, procedure, process, and outcome
variables of the drug treatment program, the evaluator, the program di-
rector, and the aftercare worker estimated the relative strength of each
possible relationship between each resource, procedure, process, and
outcome. The existence and strength of these resource-procedure,
procedure-process, and process-outcome relationships were esti-
mated, rather than measured empirically, to conserve time and money.
The strength of these links need not be expressed in monetary units or
percentages, but the staff of this program were comfortable doing this.
The result carried forward costs from resources all the way through
outcomes, making for a unique cost-effectiveness analysis.
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Although the numbers the staff provided could have been simplified to
make this example easier to calculate, it would have removed the real-
ism of this analysis. Also, the example retains the actual (and perhaps
idiosyncratic) resources, procedures, processes, and outcomes that
the staff listed for their programs.
Resource-Procedure Relationships
Resources and procedures were easy for staff to specify: Resources
were what were consumed in treatment procedures, and procedures
were the actions performed on patients.
Resources and
Their Costs
Staff seemed surprisingly comfortable with estimating costs. Table 27
shows the estimated costs for 1 month for each major resource type.
Treatment
Procedures
The next step was to ask staff what procedures usually were adminis-
tered to patients. The procedures the staff listed were—
 Group counseling.
 Relapse prevention.
 Individual counseling.
 Case management.
To provide a structure for putting numbers on resource-procedure re-
lationships, each possible combination of a resource and a procedure
was listed in a resource x procedure matrix (table 28).
The CPPOA Model—An Illustration
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Table 27. Staff estimates of resources and costs for one month
Resource Total cost
Direct service staff $2,500
Administrative staff $250
Facilities rent $500
Utilities $150
Support staff $500
Supplies $500
Urine testing $1,000
Total resource cost $5,400
Amount of Each
Resource Used in
Each Procedure
The final step in translating resource-procedure relationships into
numbers was to put numbers in each cell of the resource x procedure
matrix. These numbers were found in two basic steps. First, the time of
direct service staff, the time of support staff, and the costs of supplies
and of urine testing were distributed among procedures according to
estimated use in the procedures. The entire $1,000 cost of urine testing
was allocated to relapse prevention because it was not used in any
other treatment procedures. Because support staff assisted primarily
with relapse prevention and case management, support staff costs
were divided equally between these two procedures.
Next, costs of the remaining resources were allocated among all four
treatment procedures according to the percentage of time direct staff
spent on each procedure:
 18 percent for group counseling
 23 percent for relapse prevention
 23 percent for individual counseling
 36 percent for case management
These percentages were based on careful estimates made by the pro-
gram administrator.
Resource-Procedure Relationships
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Table 28. Resource x procedure matrix with cost estimates for each procedure
Resources
Procedures
Group
counseling
Relapse
prevention
Individual
counseling
Case
management
Direct service staff
($2,500)
18% = $612 23% = $782 23% = $782 36% = $1,224
Administrative staff
($250)
Facilities ($500 rent)
Utilities ($150)
Support staff ($500) 50% = $250 50% = $250
Supplies ($500) $100 $150 $100 $150
Urine testing ($1,000) $1,000
Total ($5,400) $712 $2,182 $882 $1,624
Change in
Processes for
Individual Patients
One of the people conducting this CPPOA, the program director, and
the aftercare worker described three types of psychosocial process that
were the focus of treatment procedures:
 Self-efficacy expectancies
 The acquisition of necessary skills, specifically:
 Relapse prevention skills
 Support access skills
 Services access skills
 Bonding with:
 Addicts and ex-offenders
 Counselors
Illustrative, hypothetical numbers were created for Patients A and B be-
fore and after participation in the program’s treatment procedures. For
example, according to the questionnaire that measured patients’
self-efficacy expectancies, Patient A and Patient B scored an 8 before
treatment began. After treatment, Patient A scored 12 and Patient B
scored 16. Percentage change was used to examine how much pro-
cesses changed during treatment (table 29).
Data were preserved at this individual patient level, as well as being
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Table 29. Percentage change of psychosocial processes for patients A and B
Processes
Patient A Patient B Average
%
changeBefore After
%
change
Before After
%
change
Self-efficacy expectancies 8 12 50% 8 16 100% 75%
Skill
acquisition
Relapse
prevention
10 12 20% 2 6 200% 110%
Support access 3 3 0% 3 6 100% 50%
Service access 30 45 50% 20 40 100% 75%
Bonding
With addicts and
ex-offenders
7 7 0% 10 5 –50% –25%
With counselors 5 15 200% 4 12 200% 200%
Average 53.33% 41.67% 80.83%
averaged, because process data is combined with outcome data in the
analysis of cost-procedure-process-outcome relationships. The follow-
ing hypothetical data are simplified to make the calculation procedures
more obvious.
Procedure-Process
Relationships:
Patient Level
Table 30 illustrates how the strength of relationships between (a) the
degree to which procedures were implemented and (b) the extent to
which psychosocial process changed could be described for individual
patients. The percentages in the cells of Patient A’s procedure x process
matrix are the same percentages calculated in table 29 for change in
processes. For example, 50 percent was entered in each cell in the
self-efficacy expectancies column. These data would be even more pre-
cise if the portion of each procedure that was devoted to changing each
process were specified. This, however, may be difficult to measure.
Some correlational statistical techniques, such as multiple regression,
may help to do this.
Procedure-Process
Relationships:
Program Level
Staff of the aftercare program estimated the percentage of time that a
given treatment procedure focused on modifying specific psychosocial
processes (table 31). All four procedures were described as affecting at
least two different psychosocial processes; all four procedures contrib-
uted via multiple processes to treatment outcomes. Even if one of the
processes (say, support access) were not affected by relapse preven-
tion, other processes would be. Staff felt comfortable using percent-
ages (rather than correlations or other measures) to estimate the
strength of relationships between procedures and processes.
Resource-Procedure Relationships
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Table 30. Procedure x process matrix for Patient A
Procedures
Processes
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Group counseling 50% 20% 0 50% 0 200%
Relapse prevention 50% 20% 0 50% 0 200%
Individual counseling 50% 20% 0 50% 0 200%
Case management 50% 20% 0 50% 0 200%
Adding Costs to
Procedure-Process
Relationships
The percentages were then used to distribute the total cost of each pro-
cedure among the processes (table 32). The total cost of changing each
of the five processes can be calculated by totaling costs in the respective
column.
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Table 31. Procedure x process matrix for the program
Procedures
Processes
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Group counseling 33% 33% 33%
Relapse prevention 20% 20% 20% 20% 20%
Individual counseling 50% 50%
Case management 75% 12.5% 12.5%
Table 32. Procedure x process matrix with cost estimates
Procedures
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Group counseling $238 $238 $238
Relapse prevention $436 $436 $436 $436 $436
Individual counseling $441 $441
Case management $1218 $203 $203
Totals $1115 $436 $436 $1218 $877 $1318
Outcomes
Process-Outcome
Relationships
The psychosocial processes listed in the preceding tables were sup-
posed to increase the likelihood that a patient would achieve four pri-
mary outcomes, defined by program staff as—
 Being drug free, that is, abstaining from drugs for a month, ac-
cording to urine tests, self-reports, and peer reports (i.e., from
other former users).
 Having stable employment, that is, having a legal full-time job for
the past month.
 Being crime free, that is, avoiding all criminal behavior for the
past month, according to self and peers as well as reports from
family and probation officers.
 Being compliant with probation and parole according to the pro-
bation officer (who met weekly with the aftercare worker).
The question was, were these outcomes actually related to changes in
the previously mentioned processes? More concretely, what were the
connections between the processes and outcomes, according to staff
and according to research?
Percentage
Contributions of
Processes to
Outcomes
Staff also were asked to estimate how much each psychosocial process
determined each of the four types of program outcomes. It was fairly
easy to obtain these estimates after several hours of discussion. Again,
the staff wished to use percentages. The results are detailed in table 33,
with percentages of each process assigned to different outcomes and
summing to 100 percent for each process (each row). For example,
staff estimated that 40 percent of the change produced by treatment
procedures in self-efficacy expectancies contributed to the outcome of
being drug free. Staff viewed relapse prevention skills as entirely (100
percent) focused on drug abstinence. Staff also reported that equal
proportions of improved skills for accessing support affected the out-
comes of drug abstinence, stable employment, absence of criminal be-
havior, and compliance with probation and parole.
Adding Costs to
Process-Outcome
Relationships
The total cost of changing a process was distributed among the out-
comes according to the percentages given earlier by staff to describe re-
lationships between processes and outcomes (table 33). The total cost
of achieving each outcome was calculated by adding up the cost figures
in each column. These costs sum to $5,400, the total cost of the pro-
gram for the month. This does not reflect the total cost of achieving
these outcomes. The total cost per outcome achieved per patient must
include the cost of participating in the therapeutic community for 6 to 9
months, plus 3 months of the aftercare program. Unfortunately, data
Outcomes
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were not available for the therapeutic community program. Although it
is tempting to assign a cost to these outcomes of three times the
monthly cost, and to then divide the cost by the proportion of patients
attaining the outcome to arrive at a cost/outcome ratio, this would seri-
ously underestimate the cost of attaining these outcomes. That ratio
completely omits the costs of the therapeutic community.
Qualitative/Quantitative Path Analysis
By constructing bar graphs of the amounts of resources focused on
each procedure, process, and outcome, it is easy to see where the costs
are and what outcomes they provide. For example, it is evident in graph
8 that the most costly procedures are relapse prevention and case man-
agement. Also, some processes absorb far more resources than do oth-
ers. As shown in graph 9, self-efficacy enhancement, skill acquisition
for service access, and both types of bonding are particularly large in-
vestments of potentially therapeutic resources.
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Table 33. Adding costs to process-outcome relationships
Processes
Outcomes
Drug-free
(complete drug
abstinence)
Stable
employment
Crime-free
(avoidance of all
criminal
behavior)
Compliance
with probation
and parole
Self-efficacy expectancies
($1115)
$446 (40%) $223 (20%) $446 (40%)
Skill
acquisition
Relapse
prevention
($436)
$436 (100%)
Support access
($436)
$109 (25%) $109 (25%) $109 (25%) $109 (25%)
Service access
($1218)
$974 (80%) $244 (20%)
Bonding
With addicts and
ex-offenders
($877)
$281 (32%) $34 (4%) $281 (32%) $281 (32%)
With counselors
($1318)
$132 (10%) $527 (40%) $132 (10%) $527 (40%)
However, the outcomes associated with these
procedures and processes differ in both the cost
of resources devoted to them and the degree to
which patients achieved what was desired. The
outcome toward which the least amount of re-
sources was directed, being crime free (graph
10), was the most likely to be achieved (by 100
percent of patients). The outcome toward which
the most resources were directed (stable employ-
ment) was the least likely to be achieved (by a rel-
atively low 65 percent of patients). These costs
may reflect the program manager’s expectation
that stable employment would be the most diffi-
cult to achieve and thus deserved more re-
sources. Nevertheless, the cost findings for each
class of variables in the CPPOA model are of po-
tential value in program management.
Most of the relapse prevention efforts resulted in
a 90-percent abstinence rate. The CPPOA model
also shows that several other procedures contrib-
uted to this outcome. However, the case manage-
ment procedure produced a less impressive out-
come. By connecting procedures to processes to
outcomes, it becomes clear that much of the case
Qualitative/Quantitative Path Analysis
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Graph 10. Costs of achieving outcomes
Graph 8. Costs of implementing procedures
Graph 9. Costs of changing processes
management effort is related to the employment outcome. Yet, stable
employment (steady work sufficient to support the patient and his or
her dependents) is the outcome attained by the lowest percentage of
patients. Perhaps this outcome would have been worse without case
management, but it does call into question the value of this procedure
for program outcomes. It also is interesting to note how much bonding
to counselors was estimated to contribute to outcomes.
Integrating Qualitative and Quantitative Models for
Formative CPPOA
The CPPOA model and its associated costs and outcomes (and
cost-outcome ratios) are based on estimated and informally observed
findings generated over the short term, rather than entirely objective
measures collected using instruments of proven reliability and validity
over several months or years.
The result is more of a qualitative and subjective, rather than a quantita-
tive and objective, understanding of treatment. The qualitative CPPOA
diagram and its associated estimates of costs and outcomes can be used
as a sort of baseline against which to compare more quantitative data
during data collection. Regular updates of the model can contrast and
replace estimations with observations, showing staff how closely their
understanding of the program matches the understanding provided by
more objective measures.
With information on cost-procedure, procedure-process, and pro-
cess-outcome relationships like that shown in the preceding example,
the CPPOA model can then be used to make decisions about program
changes or developments. In this example, it seems reasonable to keep
intact the procedures and processes related to the abstinence out-
come. In fact, the model affirms staff efforts in assisting patients in
maintaining abstinence. Some staff, for example, questioned the effi-
cacy of urine testing. Here it appears that urine testing is an important
part of the procedures that produce the desired processes and
outcomes.
Examining the cost-procedure-process-outcome model, staff can see
that the case management efforts aimed at improved employment sta-
tus may not be producing the desired outcomes. Seeing that a different
approach, one aimed at skills acquisition and self-efficacy, was more
productive in maintaining abstinence, staff may decide to decrease
some of the time devoted to case management to allow for a more fo-
cused skills-building and problem-solving employment group.
This brief description shows how the CPPOA model can be used to
make decisions about program changes. Many other program descrip-
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118
tions are embedded in the sample above. From these descriptions and
connections between costs and outcomes, a variety of more informed
program decisions can be made.
Many program managers will recognize ways to reduce the cost of treat-
ment as soon as figures show up in a resource x procedure matrix. The
decisions inspired by a resource x procedure matrix are, however, only
as good as the data on which they are based. Although estimates such as
those made above are enticingly quick and (relatively) easy to generate,
their validity is suspect. With so much in the balance, there may be
some temptation to bias estimates in favor of one’s favorite procedures.
It also can be very tempting to underestimate the cost of one’s own role
in providing treatment. Sometimes one does not realize the presence
or strength of this bias.
Although even cost data collected with carefully constructed question-
naires administered by persons not directly involved in treatment can
be biased, entirely estimated cost data may be more biased. If cost esti-
mates are used, as in the example developed here, the validity of these
estimates needs to be supported—perhaps by collecting some cost
data in the more careful, expensive way and comparing the estimated
to the observed costs.
CPPOA Research Design
If you have been trained in research design, you may be wondering
about the role of research design in CPPOA. The answer is that both ex-
perimental and correlational designs can provide useful information
for CPPOA.
Experimental
CPPOA
Most experimental designs carefully manipulate the procedure part of
the CPPOA model, usually presenting different procedures to different
patients. Sometimes the procedure to which some patients are as-
signed is to simply wait, whereas others receive treatment immediately.
A random lottery is used to decide which patients should wait and
which should receive treatment right away. Outcome measures may be
administered to the waiting-list control group, so that researchers can
tell how much of the improvement in patients who received actual
treatment procedures might be due to (a) the effects of repeatedly ad-
ministering the same outcome measures and to (b) factors other than
treatment procedures.
In variations of this experimental design, patients may be assigned ran-
domly to treatment procedures that begin after different delays. Some-
times entirely different procedures are compared for effectiveness;
sometimes different mixtures of procedures are compared.
CPPOA Research Design
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Correlational
Designs and
CPPOA
In some treatment settings, it makes sense to assign patients to
short-term waiting lists; sometimes there is more demand for services
than there are services available. In some programs, too, the proce-
dures have not yet been proven to be effective and need to be tested be-
fore being used with many patients. In most programs, however, all pa-
tients must receive treatment immediately. Patients sometimes can be
assigned randomly to different groups of treatment procedures, such
as usual treatment versus new experimental treatment.
Often, patients receive mixtures of treatment procedures that have
been carefully tailored to their individual needs, problems, and finan-
cial and employment situations. In these circumstances, CPPOA be-
comes a correlational rather than an experimental analysis.
Correlational analyses can accurately describe cost-effectiveness and
cost-benefit relationships and can provide the basis for systematic im-
provement. Sophisticated statistical techniques, as well as tables and
graphs, can be used to explore the strength of relationships between
costs, procedures, processes, and outcomes.
The CPPOA Model—An Illustration
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